This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-let-7a-3p | ABCA1 | 0.22 | 0.85543 | 0.03 | 0.97645 | mirMAP; miRNATAP | -0.39 | 0 | NA | |
2 | hsa-let-7a-3p | ABCC9 | 0.22 | 0.85543 | -0.59 | 0.22249 | mirMAP | -0.8 | 0 | NA | |
3 | hsa-let-7a-3p | ABCD2 | 0.22 | 0.85543 | 0.42 | 0.49591 | mirMAP | -0.51 | 5.0E-5 | NA | |
4 | hsa-let-7a-3p | ABI3BP | 0.22 | 0.85543 | 0.35 | 0.57111 | miRNATAP | -0.62 | 2.0E-5 | NA | |
5 | hsa-let-7a-3p | ACVR1 | 0.22 | 0.85543 | -0.1 | 0.92895 | MirTarget; miRNATAP | -0.12 | 0.00024 | NA | |
6 | hsa-let-7a-3p | ADAM23 | 0.22 | 0.85543 | -0.22 | 0.68516 | mirMAP | -0.96 | 0 | NA | |
7 | hsa-let-7a-3p | ADAMTS5 | 0.22 | 0.85543 | -0.46 | 0.44877 | mirMAP | -0.36 | 0 | NA | |
8 | hsa-let-7a-3p | ADAMTSL3 | 0.22 | 0.85543 | -0.62 | 0.25659 | MirTarget | -1.14 | 0 | NA | |
9 | hsa-let-7a-3p | ADCYAP1 | 0.22 | 0.85543 | -0.9 | 0.19378 | miRNATAP | -1.12 | 0 | NA | |
10 | hsa-let-7a-3p | ADD2 | 0.22 | 0.85543 | -0.59 | 0.48027 | mirMAP | -0.74 | 0 | NA | |
11 | hsa-let-7a-3p | AFF2 | 0.22 | 0.85543 | -0.1 | 0.89663 | mirMAP | -0.35 | 0.012 | NA | |
12 | hsa-let-7a-3p | AFF3 | 0.22 | 0.85543 | 0.07 | 0.87952 | MirTarget | -0.46 | 0.00048 | NA | |
13 | hsa-let-7a-3p | AKAP12 | 0.22 | 0.85543 | -0.67 | 0.54527 | miRNATAP | -0.88 | 0 | NA | |
14 | hsa-let-7a-3p | ALDH1L2 | 0.22 | 0.85543 | -0.66 | 0.34577 | MirTarget | -0.5 | 0 | NA | |
15 | hsa-let-7a-3p | AMIGO2 | 0.22 | 0.85543 | -0.84 | 0.41846 | MirTarget; mirMAP | -0.39 | 5.0E-5 | NA | |
16 | hsa-let-7a-3p | AMOTL1 | 0.22 | 0.85543 | -0.32 | 0.72722 | mirMAP | -0.64 | 0 | NA | |
17 | hsa-let-7a-3p | ANKRD50 | 0.22 | 0.85543 | 0.17 | 0.87284 | mirMAP | -0.19 | 4.0E-5 | NA | |
18 | hsa-let-7a-3p | ANO5 | 0.22 | 0.85543 | -1.54 | 0.03199 | mirMAP | -0.59 | 0.00256 | NA | |
19 | hsa-let-7a-3p | ANTXR1 | 0.22 | 0.85543 | -0.41 | 0.78975 | mirMAP; miRNATAP | -0.79 | 0 | NA | |
20 | hsa-miR-106b-5p | APC | 0.3 | 0.86929 | -0.2 | 0.85295 | miRNAWalker2 validate; miRTarBase | -0.22 | 0 | 23087084 | miR 106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma; Moreover we demonstrated that miR-106b downregulates APC expression by directly targeting the 3'-untranslated region of APC messenger RNA; Taken together our results suggest that miR-106b plays an important role in promoting the proliferation of human hepatoma cells and presents a novel mechanism of micro RNA-mediated direct suppression of APC expression in cancer cells |
21 | hsa-miR-148a-3p | APC | 0.1 | 0.97698 | -0.2 | 0.85295 | miRNAWalker2 validate | -0.12 | 0.00641 | NA | |
22 | hsa-miR-154-3p | APC | 0.17 | 0.5465 | -0.2 | 0.85295 | TargetScan | -0.12 | 0.00356 | NA | |
23 | hsa-miR-192-5p | APC | 0.12 | 0.97293 | -0.2 | 0.85295 | miRNAWalker2 validate | -0.11 | 0.00054 | NA | |
24 | hsa-miR-193a-3p | APC | 0.25 | 0.65436 | -0.2 | 0.85295 | miRanda | -0.15 | 0.00011 | NA | |
25 | hsa-miR-27a-3p | APC | 0.12 | 0.9588 | -0.2 | 0.85295 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.17 | 0.00984 | 22018270 | Finally the APC gene was identified as the direct and functional target of miR-27 |
26 | hsa-miR-335-3p | APC | 0.24 | 0.8845 | -0.2 | 0.85295 | mirMAP | -0.21 | 0 | NA | |
27 | hsa-miR-374a-5p | APC | 0.34 | 0.76692 | -0.2 | 0.85295 | mirMAP | -0.28 | 0 | NA | |
28 | hsa-miR-374b-5p | APC | 0.29 | 0.8357 | -0.2 | 0.85295 | mirMAP | -0.2 | 0.00044 | NA | |
29 | hsa-miR-421 | APC | 0.18 | 0.7347 | -0.2 | 0.85295 | miRanda | -0.15 | 0.0002 | NA | |
30 | hsa-miR-450b-5p | APC | 0.01 | 0.98315 | -0.2 | 0.85295 | miRNATAP | -0.17 | 6.0E-5 | NA | |
31 | hsa-miR-501-3p | APC | 0.75 | 0.55276 | -0.2 | 0.85295 | TargetScan | -0.12 | 0.00171 | NA | |
32 | hsa-miR-590-3p | APC | 0.28 | 0.59127 | -0.2 | 0.85295 | PITA; miRanda; mirMAP; miRNATAP | -0.1 | 0.00339 | NA | |
33 | hsa-miR-199a-5p | APC2 | -0.16 | 0.9358 | 0.38 | 0.36375 | mirMAP | -0.25 | 0.01352 | NA | |
34 | hsa-miR-20a-3p | APC2 | -0.46 | 0.57674 | 0.38 | 0.36375 | mirMAP | -0.17 | 0.00956 | NA | |
35 | hsa-miR-221-5p | APC2 | -0.08 | 0.8976 | 0.38 | 0.36375 | mirMAP | -0.15 | 0.02524 | NA | |
36 | hsa-miR-452-3p | APC2 | 0.17 | 0.79901 | 0.38 | 0.36375 | mirMAP | -0.17 | 0.00953 | NA | |
37 | hsa-miR-500a-3p | APC2 | 0.63 | 0.73258 | 0.38 | 0.36375 | mirMAP | -0.23 | 0.01164 | NA | |
38 | hsa-let-7a-3p | AQP9 | 0.22 | 0.85543 | 0.03 | 0.96356 | MirTarget | -0.89 | 0 | NA | |
39 | hsa-let-7a-3p | ARHGAP20 | 0.22 | 0.85543 | -0.29 | 0.53474 | MirTarget; miRNATAP | -0.61 | 0 | NA | |
40 | hsa-let-7a-3p | ARHGAP28 | 0.22 | 0.85543 | 0.02 | 0.95412 | mirMAP | -0.39 | 0.00025 | NA | |
41 | hsa-let-7a-3p | ARHGAP29 | 0.22 | 0.85543 | -0.16 | 0.86195 | mirMAP | -0.27 | 0.00025 | NA | |
42 | hsa-let-7a-3p | ARL10 | 0.22 | 0.85543 | -0.21 | 0.63068 | mirMAP | -0.55 | 0 | NA | |
43 | hsa-let-7a-3p | ARSB | 0.22 | 0.85543 | 0.25 | 0.77683 | mirMAP | -0.17 | 0.00258 | NA | |
44 | hsa-let-7a-3p | ASAH1 | 0.22 | 0.85543 | 0.39 | 0.80879 | MirTarget | -0.14 | 0.00225 | NA | |
45 | hsa-let-7a-3p | ASAP1 | 0.22 | 0.85543 | -0.41 | 0.73426 | mirMAP | -0.19 | 0.0006 | NA | |
46 | hsa-let-7a-3p | ASXL2 | 0.22 | 0.85543 | 0.15 | 0.89512 | mirMAP; miRNATAP | -0.18 | 0.00081 | NA | |
47 | hsa-let-7a-3p | ATE1 | 0.22 | 0.85543 | 0.27 | 0.75611 | mirMAP | -0.13 | 0.00265 | NA | |
48 | hsa-let-7a-3p | ATF2 | 0.22 | 0.85543 | 0.2 | 0.8347 | MirTarget; mirMAP; miRNATAP | -0.15 | 4.0E-5 | NA | |
49 | hsa-let-7a-3p | ATP6AP2 | 0.22 | 0.85543 | 0.06 | 0.96911 | mirMAP | -0.13 | 0.00027 | NA | |
50 | hsa-let-7a-3p | ATRN | 0.22 | 0.85543 | 0.42 | 0.74342 | miRNATAP | -0.26 | 8.0E-5 | NA | |
51 | hsa-let-7a-3p | ATRX | 0.22 | 0.85543 | 0.04 | 0.97477 | MirTarget; miRNATAP | -0.13 | 0.00051 | NA | |
52 | hsa-miR-34c-5p | AXIN2 | 0.02 | 0.95279 | -0.16 | 0.92249 | miRanda | -0.24 | 0.02386 | NA | |
53 | hsa-miR-582-5p | AXIN2 | 0.4 | 0.58123 | -0.16 | 0.92249 | miRNATAP | -0.54 | 0 | NA | |
54 | hsa-let-7a-3p | B3GALNT1 | 0.22 | 0.85543 | -0.71 | 0.20409 | mirMAP | -0.37 | 0.00031 | NA | |
55 | hsa-let-7a-3p | BAG4 | 0.22 | 0.85543 | 0.39 | 0.56669 | mirMAP | -0.2 | 0.00021 | NA | |
56 | hsa-let-7a-3p | BASP1 | 0.22 | 0.85543 | -0.42 | 0.63739 | miRNATAP | -0.46 | 0 | NA | |
57 | hsa-let-7a-3p | BCL6 | 0.22 | 0.85543 | -0.02 | 0.97914 | miRNATAP | -0.17 | 0.00802 | NA | |
58 | hsa-let-7a-3p | BDNF | 0.22 | 0.85543 | -0.5 | 0.16933 | MirTarget; miRNATAP | -0.24 | 0.00935 | NA | |
59 | hsa-let-7a-3p | BEND4 | 0.22 | 0.85543 | -0.29 | 0.75243 | mirMAP | -0.41 | 0.00473 | NA | |
60 | hsa-let-7a-3p | BEND6 | 0.22 | 0.85543 | -0.45 | 0.38458 | mirMAP | -0.77 | 0 | NA | |
61 | hsa-let-7a-3p | BICD2 | 0.22 | 0.85543 | 0.01 | 0.99011 | mirMAP | -0.1 | 0.00472 | NA | |
62 | hsa-let-7a-3p | BMP2K | 0.22 | 0.85543 | 0.17 | 0.84483 | mirMAP | -0.17 | 6.0E-5 | NA | |
63 | hsa-let-7a-3p | BMP3 | 0.22 | 0.85543 | -1.04 | 0.20452 | MirTarget; mirMAP | -0.82 | 0.00029 | NA | |
64 | hsa-let-7a-3p | BMPR1B | 0.22 | 0.85543 | -0.03 | 0.96601 | miRNATAP | -0.61 | 0.00028 | NA | |
65 | hsa-let-7a-3p | BMPR2 | 0.22 | 0.85543 | -0.18 | 0.9 | MirTarget; miRNATAP | -0.18 | 0.00013 | NA | |
66 | hsa-let-7a-3p | BNC2 | 0.22 | 0.85543 | -0.3 | 0.61151 | mirMAP | -0.77 | 0 | NA | |
67 | hsa-let-7a-3p | BST1 | 0.22 | 0.85543 | -0.48 | 0.33816 | MirTarget | -0.38 | 0.00024 | NA | |
68 | hsa-let-7a-3p | BTC | 0.22 | 0.85543 | -0 | 0.99638 | mirMAP | -0.2 | 0.00283 | NA | |
69 | hsa-let-7a-3p | BVES | 0.22 | 0.85543 | -0.39 | 0.30397 | mirMAP | -0.64 | 0 | NA | |
70 | hsa-let-7a-3p | CACNA1C | 0.22 | 0.85543 | -0.62 | 0.47829 | MirTarget | -0.23 | 0.03112 | NA | |
71 | hsa-let-7a-3p | CACNA2D1 | 0.22 | 0.85543 | -0.21 | 0.75224 | mirMAP | -1.24 | 0 | NA | |
72 | hsa-let-7a-3p | CACNG4 | 0.22 | 0.85543 | -1.67 | 0.05751 | MirTarget | -0.55 | 0.03405 | NA | |
73 | hsa-miR-195-3p | CACYBP | -0.12 | 0.69192 | -0.04 | 0.97693 | mirMAP | -0.15 | 0 | NA | |
74 | hsa-miR-30a-3p | CACYBP | -0.25 | 0.91709 | -0.04 | 0.97693 | MirTarget | -0.23 | 0 | NA | |
75 | hsa-miR-182-5p | CAMK2B | 0.1 | 0.97338 | -2.17 | 0.00982 | mirMAP | -0.23 | 0.04992 | NA | |
76 | hsa-miR-186-5p | CAMK2B | 0.32 | 0.85413 | -2.17 | 0.00982 | miRNAWalker2 validate; miRNATAP | -0.92 | 0 | NA | |
77 | hsa-miR-18a-5p | CAMK2B | 0.5 | 0.61264 | -2.17 | 0.00982 | mirMAP | -0.33 | 0.00078 | NA | |
78 | hsa-miR-18b-5p | CAMK2B | 0.05 | 0.89998 | -2.17 | 0.00982 | mirMAP | -0.21 | 0.03116 | NA | |
79 | hsa-miR-335-5p | CAMK2B | 0.03 | 0.97338 | -2.17 | 0.00982 | mirMAP | -0.3 | 0.01498 | NA | |
80 | hsa-miR-34a-5p | CAMK2B | 0.5 | 0.74203 | -2.17 | 0.00982 | mirMAP | -0.28 | 0.04878 | NA | |
81 | hsa-miR-362-3p | CAMK2B | 0.72 | 0.03459 | -2.17 | 0.00982 | miRanda | -0.39 | 0.00026 | NA | |
82 | hsa-miR-362-5p | CAMK2B | 0.27 | 0.75202 | -2.17 | 0.00982 | miRNATAP | -0.43 | 3.0E-5 | NA | |
83 | hsa-miR-377-3p | CAMK2B | 0.04 | 0.89351 | -2.17 | 0.00982 | mirMAP | -0.3 | 0.01013 | NA | |
84 | hsa-miR-491-5p | CAMK2B | 0.59 | 0.04526 | -2.17 | 0.00982 | miRanda | -0.24 | 0.04944 | NA | |
85 | hsa-miR-577 | CAMK2B | 1.06 | 0.32606 | -2.17 | 0.00982 | miRNATAP | -0.33 | 0 | NA | |
86 | hsa-miR-589-3p | CAMK2B | 0.84 | 0.0112 | -2.17 | 0.00982 | MirTarget | -0.47 | 0 | NA | |
87 | hsa-miR-590-3p | CAMK2B | 0.28 | 0.59127 | -2.17 | 0.00982 | miRanda | -0.42 | 0.00016 | NA | |
88 | hsa-miR-625-5p | CAMK2B | 0.69 | 0.21031 | -2.17 | 0.00982 | mirMAP | -0.4 | 3.0E-5 | NA | |
89 | hsa-miR-628-5p | CAMK2B | 0.51 | 0.35193 | -2.17 | 0.00982 | miRNATAP | -0.53 | 0.00189 | NA | |
90 | hsa-miR-940 | CAMK2B | 0.23 | 0.68006 | -2.17 | 0.00982 | PITA; miRNATAP | -0.25 | 0.0094 | NA | |
91 | hsa-miR-96-5p | CAMK2B | -0.09 | 0.92309 | -2.17 | 0.00982 | mirMAP | -0.29 | 0.01248 | NA | |
92 | hsa-miR-361-5p | CAMK2D | 0.14 | 0.9415 | 0.33 | 0.80466 | PITA; miRanda; miRNATAP | -0.15 | 0.03044 | NA | |
93 | hsa-miR-542-3p | CAMK2D | -0.19 | 0.90925 | 0.33 | 0.80466 | miRanda | -0.11 | 0.03439 | NA | |
94 | hsa-miR-708-3p | CAMK2D | -0.14 | 0.89698 | 0.33 | 0.80466 | mirMAP | -0.14 | 0.00023 | NA | |
95 | hsa-miR-181a-5p | CAMK2G | -0.03 | 0.98933 | -0.21 | 0.86839 | miRNATAP | -0.1 | 0.00195 | NA | |
96 | hsa-miR-181b-5p | CAMK2G | -0.16 | 0.93018 | -0.21 | 0.86839 | miRNATAP | -0.1 | 0.00173 | NA | |
97 | hsa-miR-30e-3p | CAMK2G | 0.22 | 0.93866 | -0.21 | 0.86839 | MirTarget | -0.1 | 0.04583 | NA | |
98 | hsa-miR-628-5p | CAMK2G | 0.51 | 0.35193 | -0.21 | 0.86839 | MirTarget; PITA; miRNATAP | -0.17 | 0 | NA | |
99 | hsa-let-7a-3p | CCDC102B | 0.22 | 0.85543 | -0.45 | 0.1566 | MirTarget | -0.29 | 0.00016 | NA | |
100 | hsa-let-7a-3p | CCDC50 | 0.22 | 0.85543 | -0.18 | 0.8903 | miRNATAP | -0.14 | 0 | NA | |
101 | hsa-miR-15a-5p | CCND1 | 0.07 | 0.96484 | 0.25 | 0.89067 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.13 | 0.01564 | 22922827 | CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR |
102 | hsa-miR-15b-5p | CCND1 | 0.27 | 0.87097 | 0.25 | 0.89067 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.1 | 0.03897 | NA | |
103 | hsa-miR-16-5p | CCND1 | -0.01 | 0.99448 | 0.25 | 0.89067 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.13 | 0.00823 | 23991964; 22922827; 18483394 | At the molecular level our results further revealed that cyclin D1 expression was negatively regulated by miR-16;CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR;Truncation in CCND1 mRNA alters miR 16 1 regulation in mantle cell lymphoma; Furthermore we demonstrated that this truncation alters miR-16-1 binding sites and through the use of reporter constructs we were able to show that miR-16-1 regulates CCND1 mRNA expression; This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL |
104 | hsa-miR-195-5p | CCND1 | -0.34 | 0.74962 | 0.25 | 0.89067 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.14 | 0.00272 | 21350001; 26631043; 25823925 | Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497 miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer;MiR 195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1; The present study was to evaluate the level of miR-195 and cyclin D1 in CC tissues and cells; We further investigated the molecular mechanisms of miR-195 and cyclin D1 in CC cell lines HeLa and SiHa; Furthermore the expression of miR-195 was inversely proportional to that of cyclin D1 mRNA or protein p = 0.013 p = 0.015 respectively; However the inhibitor of miR-195 promoted the expression of cyclin D1 and cell proliferation; In conclusion our data suggest that miR-195 may have the potential role in treatment of CC patients as well as miR-195 is a novel regulator of invasiveness and tumorigenicity in CC cells by targeting cyclin D1;MicroRNA profiling identifies MiR 195 suppresses osteosarcoma cell metastasis by targeting CCND1; Meanwhile CCND1 was identified as the target gene of miR-195 and further studied; More importantly using real-time PCR we evaluated the expression of miR-195 and CCND1 in osteosarcoma samples from 107 frozen biopsy tissues and 99 formalin- or paraformalin-fixed paraffin-embedded FFPE tissues; Results indicated lowly expressed miR-195 or highly CCND1 correlated with positive overall survival and their expression inversely related to each other; In summary our study suggests miR-195 functions as a tumor metastasis suppressor gene by down-regulating CCND1 and can be used as a potential target in the treatment of osteosarcoma |
105 | hsa-miR-26b-5p | CCND1 | 0.02 | 0.99038 | 0.25 | 0.89067 | miRNAWalker2 validate | -0.13 | 0.03302 | NA | |
106 | hsa-miR-29c-3p | CCND1 | -0.16 | 0.94272 | 0.25 | 0.89067 | mirMAP | -0.14 | 0.00181 | NA | |
107 | hsa-miR-301a-3p | CCND2 | 0.11 | 0.83169 | 0.17 | 0.92031 | miRNAWalker2 validate | -0.18 | 0.02477 | NA | |
108 | hsa-let-7a-3p | CCPG1 | 0.22 | 0.85543 | -0.16 | 0.90622 | mirMAP | -0.18 | 0.00016 | NA | |
109 | hsa-let-7a-3p | CD109 | 0.22 | 0.85543 | -0.24 | 0.78871 | mirMAP | -0.58 | 7.0E-5 | NA | |
110 | hsa-let-7a-3p | CD302 | 0.22 | 0.85543 | -0.05 | 0.96052 | mirMAP | -0.17 | 0.00116 | NA | |
111 | hsa-let-7a-3p | CD38 | 0.22 | 0.85543 | 0.28 | 0.61945 | MirTarget | -0.66 | 4.0E-5 | NA | |
112 | hsa-let-7a-3p | CDC14A | 0.22 | 0.85543 | -0.02 | 0.9701 | mirMAP | -0.15 | 0.00458 | NA | |
113 | hsa-let-7a-3p | CDC42EP3 | 0.22 | 0.85543 | -0.16 | 0.87255 | MirTarget; mirMAP | -0.25 | 3.0E-5 | NA | |
114 | hsa-let-7a-3p | CDK17 | 0.22 | 0.85543 | 0.13 | 0.89542 | MirTarget; miRNATAP | -0.12 | 0.00022 | NA | |
115 | hsa-let-7a-3p | CDS2 | 0.22 | 0.85543 | 0.14 | 0.90229 | mirMAP | -0.12 | 0.00961 | NA | |
116 | hsa-let-7a-3p | CFL2 | 0.22 | 0.85543 | -0.17 | 0.83413 | mirMAP | -0.42 | 0 | NA | |
117 | hsa-miR-24-3p | CHD8 | 0.05 | 0.98527 | 0.23 | 0.87207 | miRNAWalker2 validate | -0.17 | 0.00183 | NA | |
118 | hsa-let-7a-3p | CHL1 | 0.22 | 0.85543 | -0.1 | 0.86218 | MirTarget; miRNATAP | -0.94 | 0 | NA | |
119 | hsa-let-7a-3p | CHM | 0.22 | 0.85543 | 0.03 | 0.97474 | MirTarget | -0.13 | 0.00246 | NA | |
120 | hsa-miR-1254 | CHP2 | 0.49 | 0.19552 | -1.47 | 0.1548 | miRNATAP | -0.41 | 0.02445 | NA | |
121 | hsa-let-7a-3p | CHST2 | 0.22 | 0.85543 | 0.01 | 0.98837 | MirTarget | -0.3 | 0.0002 | NA | |
122 | hsa-let-7a-3p | CLIC4 | 0.22 | 0.85543 | -0.32 | 0.83486 | MirTarget | -0.38 | 0 | NA | |
123 | hsa-let-7a-3p | CLIP1 | 0.22 | 0.85543 | 0.01 | 0.99459 | miRNATAP | -0.13 | 3.0E-5 | NA | |
124 | hsa-let-7a-3p | CLOCK | 0.22 | 0.85543 | 0.11 | 0.90421 | MirTarget | -0.12 | 0.02498 | NA | |
125 | hsa-let-7a-3p | CNR1 | 0.22 | 0.85543 | -0.41 | 0.59275 | mirMAP | -0.91 | 0 | NA | |
126 | hsa-let-7a-3p | CNTN1 | 0.22 | 0.85543 | -0.7 | 0.42296 | MirTarget; miRNATAP | -1.19 | 0 | NA | |
127 | hsa-let-7a-3p | COL11A1 | 0.22 | 0.85543 | -0.44 | 0.71516 | MirTarget; miRNATAP | -0.97 | 0 | NA | |
128 | hsa-let-7a-3p | COL12A1 | 0.22 | 0.85543 | -0.32 | 0.85805 | miRNATAP | -0.53 | 0 | NA | |
129 | hsa-let-7a-3p | COL15A1 | 0.22 | 0.85543 | -0.29 | 0.84045 | MirTarget | -0.44 | 0 | NA | |
130 | hsa-let-7a-3p | COL1A2 | 0.22 | 0.85543 | -0.45 | 0.85135 | MirTarget | -0.58 | 0 | NA | |
131 | hsa-let-7a-3p | COL4A1 | 0.22 | 0.85543 | -0.39 | 0.84353 | miRNATAP | -0.37 | 0 | NA | |
132 | hsa-let-7a-3p | COL9A1 | 0.22 | 0.85543 | -1.12 | 0.11959 | mirMAP | -0.49 | 0.0225 | NA | |
133 | hsa-let-7a-3p | CORO1C | 0.22 | 0.85543 | 0.11 | 0.94638 | MirTarget; miRNATAP | -0.12 | 0.00019 | NA | |
134 | hsa-let-7a-3p | CPEB4 | 0.22 | 0.85543 | -0.27 | 0.79855 | mirMAP; miRNATAP | -0.2 | 5.0E-5 | NA | |
135 | hsa-miR-493-5p | CREBBP | -0.23 | 0.73198 | 0.07 | 0.96314 | miRNATAP | -0.13 | 0.00036 | NA | |
136 | hsa-let-7a-3p | CRISPLD1 | 0.22 | 0.85543 | -0.38 | 0.4497 | MirTarget; miRNATAP | -0.82 | 0 | NA | |
137 | hsa-miR-21-5p | CSNK1A1 | 0.15 | 0.97024 | -0.04 | 0.98107 | miRNAWalker2 validate | -0.1 | 0.01247 | NA | |
138 | hsa-miR-30e-5p | CSNK1A1 | 0.07 | 0.97968 | -0.04 | 0.98107 | MirTarget | -0.11 | 0.00277 | NA | |
139 | hsa-miR-330-3p | CSNK1A1L | -0 | 0.9945 | 0.09 | 0.90544 | PITA | -0.16 | 0.04934 | NA | |
140 | hsa-miR-26a-5p | CSNK2A1 | -0.01 | 0.99772 | 0.07 | 0.95967 | mirMAP | -0.15 | 0.03995 | NA | |
141 | hsa-miR-146b-5p | CSNK2A2 | 0.4 | 0.83751 | -0.05 | 0.96212 | miRanda | -0.17 | 0 | NA | |
142 | hsa-miR-212-3p | CSNK2A2 | 0.02 | 0.97323 | -0.05 | 0.96212 | mirMAP | -0.12 | 0.00416 | NA | |
143 | hsa-miR-92b-3p | CSNK2A2 | 0.57 | 0.68932 | -0.05 | 0.96212 | mirMAP | -0.11 | 0.00058 | NA | |
144 | hsa-miR-140-5p | CTNNB1 | 0.23 | 0.84733 | 0.27 | 0.89738 | miRanda | -0.14 | 0.00185 | NA | |
145 | hsa-let-7a-3p | CTSC | 0.22 | 0.85543 | -0.01 | 0.99667 | mirMAP | -0.13 | 0.00792 | NA | |
146 | hsa-let-7a-3p | CUL4B | 0.22 | 0.85543 | -0.02 | 0.98956 | mirMAP | -0.1 | 0.00249 | NA | |
147 | hsa-let-7a-3p | CX3CR1 | 0.22 | 0.85543 | 0.43 | 0.29379 | MirTarget | -0.65 | 0 | NA | |
148 | hsa-let-7a-3p | CXXC4 | 0.22 | 0.85543 | -0.79 | 0.21218 | mirMAP | -0.32 | 0.01577 | NA | |
149 | hsa-let-7f-1-3p | CXXC4 | 0.31 | 0.69341 | -0.79 | 0.21218 | mirMAP | -0.52 | 0.00404 | NA | |
150 | hsa-miR-126-5p | CXXC4 | -0.08 | 0.95664 | -0.79 | 0.21218 | MirTarget; mirMAP | -0.43 | 0.00513 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | WNT SIGNALING PATHWAY | 78 | 351 | 5.661e-51 | 2.634e-47 |
2 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 140 | 1672 | 1.801e-38 | 4.19e-35 |
3 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 103 | 1021 | 1.675e-34 | 2.599e-31 |
4 | NEUROGENESIS | 120 | 1402 | 1.86e-33 | 2.164e-30 |
5 | CANONICAL WNT SIGNALING PATHWAY | 36 | 95 | 5.13e-33 | 4.774e-30 |
6 | REGULATION OF CELL DIFFERENTIATION | 123 | 1492 | 9.363e-33 | 7.261e-30 |
7 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 103 | 1142 | 2.329e-30 | 1.548e-27 |
8 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 83 | 788 | 5.883e-29 | 3.041e-26 |
9 | CIRCULATORY SYSTEM DEVELOPMENT | 83 | 788 | 5.883e-29 | 3.041e-26 |
10 | REGULATION OF WNT SIGNALING PATHWAY | 51 | 310 | 8.19e-27 | 3.464e-24 |
11 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 109 | 1395 | 7.707e-27 | 3.464e-24 |
12 | CELL DEVELOPMENT | 110 | 1426 | 1.255e-26 | 4.864e-24 |
13 | NEURON DIFFERENTIATION | 84 | 874 | 1.608e-26 | 5.756e-24 |
14 | REGULATION OF CELL DEVELOPMENT | 81 | 836 | 8.449e-26 | 2.808e-23 |
15 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 80 | 823 | 1.425e-25 | 4.42e-23 |
16 | TISSUE DEVELOPMENT | 112 | 1518 | 1.69e-25 | 4.915e-23 |
17 | TUBE DEVELOPMENT | 65 | 552 | 2.121e-25 | 5.806e-23 |
18 | REGULATION OF ORGAN MORPHOGENESIS | 44 | 242 | 4.307e-25 | 1.113e-22 |
19 | POSITIVE REGULATION OF CELL COMMUNICATION | 110 | 1532 | 4.704e-24 | 1.152e-21 |
20 | NON CANONICAL WNT SIGNALING PATHWAY | 34 | 140 | 6.056e-24 | 1.409e-21 |
21 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 125 | 1929 | 1.683e-23 | 3.729e-21 |
22 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 83 | 957 | 3.223e-23 | 6.817e-21 |
23 | ORGAN MORPHOGENESIS | 77 | 841 | 5.518e-23 | 1.116e-20 |
24 | TISSUE MORPHOGENESIS | 59 | 533 | 9.716e-22 | 1.884e-19 |
25 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 73 | 801 | 1.105e-21 | 2.057e-19 |
26 | HEART DEVELOPMENT | 55 | 466 | 1.244e-21 | 2.226e-19 |
27 | REGULATION OF CELL DEATH | 102 | 1472 | 4.328e-21 | 7.458e-19 |
28 | NEGATIVE REGULATION OF CELL COMMUNICATION | 90 | 1192 | 5.042e-21 | 8.379e-19 |
29 | NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 36 | 197 | 8.433e-21 | 1.353e-18 |
30 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 69 | 750 | 9.677e-21 | 1.501e-18 |
31 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 56 | 513 | 2.215e-20 | 3.325e-18 |
32 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 108 | 1656 | 2.385e-20 | 3.468e-18 |
33 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 101 | 1492 | 3.829e-20 | 5.399e-18 |
34 | MORPHOGENESIS OF AN EPITHELIUM | 49 | 400 | 4.697e-20 | 6.428e-18 |
35 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 45 | 337 | 5.433e-20 | 7.222e-18 |
36 | CELLULAR COMPONENT MORPHOGENESIS | 75 | 900 | 5.675e-20 | 7.335e-18 |
37 | TUBE MORPHOGENESIS | 44 | 323 | 6.507e-20 | 8.184e-18 |
38 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 95 | 1360 | 7.523e-20 | 9.212e-18 |
39 | POSITIVE REGULATION OF GENE EXPRESSION | 109 | 1733 | 2.361e-19 | 2.817e-17 |
40 | EPITHELIUM DEVELOPMENT | 76 | 945 | 2.471e-19 | 2.874e-17 |
41 | REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 37 | 236 | 5.386e-19 | 6.113e-17 |
42 | VASCULATURE DEVELOPMENT | 51 | 469 | 1.456e-18 | 1.614e-16 |
43 | EMBRYO DEVELOPMENT | 72 | 894 | 2.282e-18 | 2.469e-16 |
44 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 109 | 1791 | 2.715e-18 | 2.871e-16 |
45 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 58 | 609 | 3.118e-18 | 3.224e-16 |
46 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 111 | 1848 | 3.245e-18 | 3.282e-16 |
47 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 78 | 1036 | 3.726e-18 | 3.612e-16 |
48 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 78 | 1036 | 3.726e-18 | 3.612e-16 |
49 | EMBRYONIC MORPHOGENESIS | 54 | 539 | 5.326e-18 | 5.057e-16 |
50 | REGULATION OF STEM CELL DIFFERENTIATION | 26 | 113 | 5.746e-18 | 5.347e-16 |
51 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 65 | 771 | 1.265e-17 | 1.154e-15 |
52 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 82 | 1152 | 1.301e-17 | 1.164e-15 |
53 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 108 | 1805 | 1.385e-17 | 1.216e-15 |
54 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 87 | 1275 | 1.551e-17 | 1.337e-15 |
55 | LOCOMOTION | 80 | 1114 | 2.07e-17 | 1.751e-15 |
56 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 69 | 872 | 3.195e-17 | 2.654e-15 |
57 | INTRACELLULAR SIGNAL TRANSDUCTION | 98 | 1572 | 4.276e-17 | 3.49e-15 |
58 | POSITIVE REGULATION OF CELL DEVELOPMENT | 49 | 472 | 4.815e-17 | 3.862e-15 |
59 | SENSORY ORGAN DEVELOPMENT | 50 | 493 | 5.943e-17 | 4.687e-15 |
60 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 80 | 1135 | 6.081e-17 | 4.716e-15 |
61 | CELL FATE COMMITMENT | 34 | 227 | 6.361e-17 | 4.852e-15 |
62 | REGULATION OF CELL MORPHOGENESIS | 53 | 552 | 6.967e-17 | 5.229e-15 |
63 | NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 29 | 162 | 9.697e-17 | 7.162e-15 |
64 | MESENCHYME DEVELOPMENT | 31 | 190 | 1.294e-16 | 9.411e-15 |
65 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 105 | 1784 | 1.38e-16 | 9.877e-15 |
66 | RESPONSE TO ENDOGENOUS STIMULUS | 92 | 1450 | 1.607e-16 | 1.133e-14 |
67 | REGULATION OF PROTEIN MODIFICATION PROCESS | 102 | 1710 | 1.708e-16 | 1.186e-14 |
68 | HEAD DEVELOPMENT | 60 | 709 | 2.129e-16 | 1.457e-14 |
69 | BLOOD VESSEL MORPHOGENESIS | 42 | 364 | 2.186e-16 | 1.474e-14 |
70 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 98 | 1618 | 2.857e-16 | 1.899e-14 |
71 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 52 | 554 | 3.609e-16 | 2.365e-14 |
72 | NEGATIVE REGULATION OF CELL DEATH | 67 | 872 | 4.244e-16 | 2.743e-14 |
73 | WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY | 16 | 39 | 5.073e-16 | 3.234e-14 |
74 | REGULATION OF TRANSPORT | 104 | 1804 | 8.156e-16 | 5.128e-14 |
75 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 72 | 1004 | 1.118e-15 | 6.86e-14 |
76 | REGULATION OF CELL PROLIFERATION | 92 | 1496 | 1.12e-15 | 6.86e-14 |
77 | RESPONSE TO GROWTH FACTOR | 47 | 475 | 1.399e-15 | 8.453e-14 |
78 | HEART MORPHOGENESIS | 31 | 212 | 3.062e-15 | 1.827e-13 |
79 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 70 | 983 | 4.19e-15 | 2.468e-13 |
80 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 86 | 1381 | 5.599e-15 | 3.256e-13 |
81 | SKELETAL SYSTEM DEVELOPMENT | 45 | 455 | 5.913e-15 | 3.397e-13 |
82 | CELL PROJECTION ORGANIZATION | 66 | 902 | 7.711e-15 | 4.376e-13 |
83 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 35 | 285 | 1.139e-14 | 6.385e-13 |
84 | NEURON PROJECTION DEVELOPMENT | 49 | 545 | 1.458e-14 | 8.075e-13 |
85 | PROTEIN PHOSPHORYLATION | 67 | 944 | 2.048e-14 | 1.121e-12 |
86 | REGULATION OF NEURON DIFFERENTIATION | 49 | 554 | 2.74e-14 | 1.483e-12 |
87 | REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 22 | 110 | 4.739e-14 | 2.478e-12 |
88 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 60 | 799 | 4.721e-14 | 2.478e-12 |
89 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 69 | 1008 | 4.667e-14 | 2.478e-12 |
90 | REGULATION OF BINDING | 34 | 283 | 5.287e-14 | 2.733e-12 |
91 | STEM CELL DIFFERENTIATION | 28 | 190 | 5.637e-14 | 2.882e-12 |
92 | NEGATIVE REGULATION OF GENE EXPRESSION | 88 | 1493 | 6.218e-14 | 3.145e-12 |
93 | MUSCLE STRUCTURE DEVELOPMENT | 42 | 432 | 8.907e-14 | 4.457e-12 |
94 | REGULATION OF EMBRYONIC DEVELOPMENT | 22 | 114 | 1.03e-13 | 5.1e-12 |
95 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 88 | 1517 | 1.539e-13 | 7.537e-12 |
96 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 88 | 1518 | 1.597e-13 | 7.741e-12 |
97 | EMBRYONIC ORGAN DEVELOPMENT | 40 | 406 | 2.311e-13 | 1.109e-11 |
98 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 56 | 740 | 2.599e-13 | 1.234e-11 |
99 | GROWTH | 40 | 410 | 3.179e-13 | 1.494e-11 |
100 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 57 | 767 | 3.323e-13 | 1.546e-11 |
101 | OUTFLOW TRACT MORPHOGENESIS | 16 | 56 | 3.766e-13 | 1.735e-11 |
102 | MESENCHYMAL CELL DIFFERENTIATION | 23 | 134 | 3.846e-13 | 1.755e-11 |
103 | RESPONSE TO LIPID | 62 | 888 | 4.41e-13 | 1.992e-11 |
104 | REGULATION OF DEVELOPMENTAL GROWTH | 33 | 289 | 5.324e-13 | 2.382e-11 |
105 | NEURON DEVELOPMENT | 53 | 687 | 5.63e-13 | 2.495e-11 |
106 | CELLULAR RESPONSE TO LIPID | 42 | 457 | 5.931e-13 | 2.583e-11 |
107 | PATTERN SPECIFICATION PROCESS | 40 | 418 | 5.939e-13 | 2.583e-11 |
108 | REGIONALIZATION | 34 | 311 | 8.225e-13 | 3.544e-11 |
109 | REGULATION OF HYDROLASE ACTIVITY | 79 | 1327 | 9.028e-13 | 3.819e-11 |
110 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 25 | 167 | 8.951e-13 | 3.819e-11 |
111 | REGULATION OF MAPK CASCADE | 51 | 660 | 1.499e-12 | 6.285e-11 |
112 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 40 | 437 | 2.458e-12 | 1.012e-10 |
113 | REGULATION OF CELLULAR RESPONSE TO STRESS | 52 | 691 | 2.45e-12 | 1.012e-10 |
114 | POSITIVE REGULATION OF CELL DEATH | 48 | 605 | 2.778e-12 | 1.134e-10 |
115 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 24 | 162 | 3.238e-12 | 1.31e-10 |
116 | REGULATION OF OSSIFICATION | 25 | 178 | 3.851e-12 | 1.545e-10 |
117 | DEVELOPMENTAL GROWTH | 34 | 333 | 5.702e-12 | 2.267e-10 |
118 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 67 | 7.859e-12 | 3.099e-10 |
119 | REGULATION OF CELL PROJECTION ORGANIZATION | 45 | 558 | 8.012e-12 | 3.133e-10 |
120 | PHOSPHORYLATION | 73 | 1228 | 8.116e-12 | 3.147e-10 |
121 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 28 | 232 | 8.369e-12 | 3.218e-10 |
122 | POSITIVE REGULATION OF CELL PROLIFERATION | 56 | 814 | 1.191e-11 | 4.542e-10 |
123 | REGULATION OF GROWTH | 48 | 633 | 1.385e-11 | 5.241e-10 |
124 | NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 20 | 117 | 1.443e-11 | 5.416e-10 |
125 | EYE DEVELOPMENT | 33 | 326 | 1.488e-11 | 5.541e-10 |
126 | ANGIOGENESIS | 31 | 293 | 2.015e-11 | 7.439e-10 |
127 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 37 | 408 | 2.209e-11 | 8.094e-10 |
128 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 58 | 876 | 2.299e-11 | 8.356e-10 |
129 | DIGESTIVE SYSTEM DEVELOPMENT | 22 | 148 | 2.443e-11 | 8.812e-10 |
130 | NEURAL TUBE DEVELOPMENT | 22 | 149 | 2.8e-11 | 1.002e-09 |
131 | POSITIVE REGULATION OF OSSIFICATION | 17 | 84 | 3.013e-11 | 1.07e-09 |
132 | CELL MOTILITY | 56 | 835 | 3.204e-11 | 1.121e-09 |
133 | LOCALIZATION OF CELL | 56 | 835 | 3.204e-11 | 1.121e-09 |
134 | BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY | 10 | 22 | 4.938e-11 | 1.715e-09 |
135 | POSITIVE REGULATION OF LOCOMOTION | 37 | 420 | 5.122e-11 | 1.765e-09 |
136 | POSITIVE REGULATION OF KINASE ACTIVITY | 40 | 482 | 5.163e-11 | 1.766e-09 |
137 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 22 | 154 | 5.441e-11 | 1.848e-09 |
138 | CELLULAR RESPONSE TO RETINOIC ACID | 15 | 65 | 6.046e-11 | 2.039e-09 |
139 | SINGLE ORGANISM BEHAVIOR | 35 | 384 | 6.799e-11 | 2.276e-09 |
140 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 26 | 220 | 7.547e-11 | 2.508e-09 |
141 | CELL PROLIFERATION | 48 | 672 | 1.098e-10 | 3.623e-09 |
142 | BEHAVIOR | 41 | 516 | 1.123e-10 | 3.68e-09 |
143 | REGULATION OF RESPONSE TO STRESS | 79 | 1468 | 1.337e-10 | 4.351e-09 |
144 | EMBRYONIC ORGAN MORPHOGENESIS | 29 | 279 | 1.392e-10 | 4.498e-09 |
145 | RHYTHMIC PROCESS | 30 | 298 | 1.466e-10 | 4.705e-09 |
146 | UROGENITAL SYSTEM DEVELOPMENT | 30 | 299 | 1.592e-10 | 5.074e-09 |
147 | MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 20 | 134 | 1.839e-10 | 5.821e-09 |
148 | RESPONSE TO RETINOIC ACID | 18 | 107 | 2.001e-10 | 6.251e-09 |
149 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 48 | 684 | 2.002e-10 | 6.251e-09 |
150 | RESPIRATORY SYSTEM DEVELOPMENT | 24 | 197 | 2.169e-10 | 6.727e-09 |
151 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 30 | 303 | 2.204e-10 | 6.791e-09 |
152 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 13 | 50 | 2.31e-10 | 7.07e-09 |
153 | TAXIS | 38 | 464 | 2.339e-10 | 7.114e-09 |
154 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 35 | 404 | 2.728e-10 | 8.241e-09 |
155 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 96 | 1977 | 2.814e-10 | 8.448e-09 |
156 | NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT | 10 | 26 | 3.703e-10 | 1.104e-08 |
157 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 57 | 917 | 3.894e-10 | 1.154e-08 |
158 | MUSCLE CELL DIFFERENTIATION | 26 | 237 | 3.93e-10 | 1.157e-08 |
159 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 18 | 112 | 4.35e-10 | 1.273e-08 |
160 | REGULATION OF MUSCLE ADAPTATION | 14 | 63 | 4.538e-10 | 1.32e-08 |
161 | SENSORY ORGAN MORPHOGENESIS | 26 | 239 | 4.724e-10 | 1.365e-08 |
162 | NEURON PROJECTION GUIDANCE | 24 | 205 | 4.957e-10 | 1.424e-08 |
163 | REGULATION OF SYNAPSE ORGANIZATION | 18 | 113 | 5.055e-10 | 1.443e-08 |
164 | REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 13 | 53 | 5.109e-10 | 1.449e-08 |
165 | BIOLOGICAL ADHESION | 61 | 1032 | 6.487e-10 | 1.829e-08 |
166 | TUBE FORMATION | 19 | 129 | 6.627e-10 | 1.858e-08 |
167 | CELLULAR RESPONSE TO ACID CHEMICAL | 22 | 175 | 6.74e-10 | 1.878e-08 |
168 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 20 | 144 | 6.842e-10 | 1.895e-08 |
169 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 19 | 131 | 8.663e-10 | 2.385e-08 |
170 | SOMITE DEVELOPMENT | 15 | 78 | 9.409e-10 | 2.575e-08 |
171 | EPITHELIAL TO MESENCHYMAL TRANSITION | 13 | 56 | 1.071e-09 | 2.913e-08 |
172 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 34 | 406 | 1.199e-09 | 3.244e-08 |
173 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 23 | 197 | 1.206e-09 | 3.244e-08 |
174 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 37 | 470 | 1.217e-09 | 3.253e-08 |
175 | REGULATION OF CELL ADHESION | 44 | 629 | 1.313e-09 | 3.492e-08 |
176 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 28 | 289 | 1.454e-09 | 3.845e-08 |
177 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 32 | 368 | 1.478e-09 | 3.885e-08 |
178 | REGULATION OF KINASE ACTIVITY | 50 | 776 | 1.54e-09 | 4.026e-08 |
179 | REGULATION OF PROTEIN IMPORT | 22 | 183 | 1.59e-09 | 4.134e-08 |
180 | NEURAL TUBE FORMATION | 16 | 94 | 1.709e-09 | 4.419e-08 |
181 | DIGESTIVE TRACT MORPHOGENESIS | 12 | 48 | 1.881e-09 | 4.835e-08 |
182 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 43 | 616 | 2.176e-09 | 5.563e-08 |
183 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 46 | 689 | 2.398e-09 | 6.097e-08 |
184 | NEGATIVE REGULATION OF CELL PROLIFERATION | 44 | 643 | 2.58e-09 | 6.525e-08 |
185 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 13 | 60 | 2.668e-09 | 6.711e-08 |
186 | KIDNEY EPITHELIUM DEVELOPMENT | 18 | 125 | 2.713e-09 | 6.787e-08 |
187 | REGULATION OF SYSTEM PROCESS | 38 | 507 | 2.835e-09 | 7.055e-08 |
188 | CELL CELL SIGNALING | 49 | 767 | 3.004e-09 | 7.435e-08 |
189 | REGULATION OF CELL SUBSTRATE ADHESION | 21 | 173 | 3.14e-09 | 7.731e-08 |
190 | RESPONSE TO ACID CHEMICAL | 29 | 319 | 3.217e-09 | 7.877e-08 |
191 | PALATE DEVELOPMENT | 15 | 85 | 3.292e-09 | 8.02e-08 |
192 | NEURON PROJECTION MORPHOGENESIS | 33 | 402 | 3.487e-09 | 8.451e-08 |
193 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 61 | 1079 | 3.578e-09 | 8.627e-08 |
194 | REGULATION OF PROTEIN LOCALIZATION | 56 | 950 | 3.848e-09 | 9.23e-08 |
195 | REGULATION OF NEURON APOPTOTIC PROCESS | 22 | 192 | 3.947e-09 | 9.418e-08 |
196 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 28 | 303 | 4.198e-09 | 9.965e-08 |
197 | POSITIVE REGULATION OF MAPK CASCADE | 36 | 470 | 4.247e-09 | 1.003e-07 |
198 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 24 | 229 | 4.682e-09 | 1.1e-07 |
199 | REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 31 | 365 | 4.707e-09 | 1.101e-07 |
200 | SYNAPSE ORGANIZATION | 19 | 145 | 4.935e-09 | 1.142e-07 |
201 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 54 | 905 | 4.924e-09 | 1.142e-07 |
202 | REPRODUCTIVE SYSTEM DEVELOPMENT | 33 | 408 | 5.04e-09 | 1.161e-07 |
203 | NEURAL CREST CELL DIFFERENTIATION | 14 | 75 | 5.151e-09 | 1.181e-07 |
204 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 28 | 306 | 5.222e-09 | 1.191e-07 |
205 | CARTILAGE DEVELOPMENT | 19 | 147 | 6.218e-09 | 1.411e-07 |
206 | SEGMENTATION | 15 | 89 | 6.365e-09 | 1.438e-07 |
207 | REGULATION OF CYTOSKELETON ORGANIZATION | 37 | 502 | 7.222e-09 | 1.623e-07 |
208 | MIDBRAIN DEVELOPMENT | 15 | 90 | 7.462e-09 | 1.669e-07 |
209 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 10 | 34 | 7.617e-09 | 1.696e-07 |
210 | REGULATION OF CYTOPLASMIC TRANSPORT | 36 | 481 | 7.792e-09 | 1.727e-07 |
211 | CARDIAC CHAMBER MORPHOGENESIS | 16 | 104 | 7.83e-09 | 1.727e-07 |
212 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 28 | 312 | 8.011e-09 | 1.758e-07 |
213 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 23 | 218 | 8.65e-09 | 1.89e-07 |
214 | REGULATION OF CELL CYCLE | 55 | 949 | 9.675e-09 | 2.104e-07 |
215 | REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 12 | 55 | 1.008e-08 | 2.171e-07 |
216 | POSITIVE REGULATION OF GROWTH | 24 | 238 | 1.004e-08 | 2.171e-07 |
217 | REGULATION OF GTPASE ACTIVITY | 44 | 673 | 1.018e-08 | 2.183e-07 |
218 | POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 19 | 152 | 1.089e-08 | 2.324e-07 |
219 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 35 | 465 | 1.096e-08 | 2.329e-07 |
220 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 46 | 724 | 1.115e-08 | 2.358e-07 |
221 | REGULATION OF CELLULAR LOCALIZATION | 67 | 1277 | 1.131e-08 | 2.381e-07 |
222 | APPENDAGE DEVELOPMENT | 20 | 169 | 1.158e-08 | 2.417e-07 |
223 | LIMB DEVELOPMENT | 20 | 169 | 1.158e-08 | 2.417e-07 |
224 | REGULATION OF CELL JUNCTION ASSEMBLY | 13 | 68 | 1.346e-08 | 2.797e-07 |
225 | REGULATION OF JUN KINASE ACTIVITY | 14 | 81 | 1.457e-08 | 3.014e-07 |
226 | CELL PART MORPHOGENESIS | 42 | 633 | 1.471e-08 | 3.029e-07 |
227 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 25 | 262 | 1.513e-08 | 3.087e-07 |
228 | GASTRULATION | 19 | 155 | 1.507e-08 | 3.087e-07 |
229 | DORSAL VENTRAL AXIS SPECIFICATION | 8 | 20 | 1.555e-08 | 3.16e-07 |
230 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 22 | 207 | 1.596e-08 | 3.214e-07 |
231 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 22 | 207 | 1.596e-08 | 3.214e-07 |
232 | REGULATION OF ORGANELLE ORGANIZATION | 63 | 1178 | 1.606e-08 | 3.22e-07 |
233 | EPITHELIAL CELL DIFFERENTIATION | 36 | 495 | 1.638e-08 | 3.271e-07 |
234 | REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 14 | 1.899e-08 | 3.761e-07 |
235 | CONVERGENT EXTENSION | 7 | 14 | 1.899e-08 | 3.761e-07 |
236 | RESPONSE TO DRUG | 33 | 431 | 1.929e-08 | 3.803e-07 |
237 | CELL ACTIVATION | 39 | 568 | 1.968e-08 | 3.863e-07 |
238 | REGULATION OF TRANSFERASE ACTIVITY | 54 | 946 | 2.225e-08 | 4.349e-07 |
239 | REGULATION OF JNK CASCADE | 19 | 159 | 2.294e-08 | 4.467e-07 |
240 | REGULATION OF CELL GROWTH | 31 | 391 | 2.358e-08 | 4.572e-07 |
241 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 21 | 194 | 2.453e-08 | 4.717e-07 |
242 | CONNECTIVE TISSUE DEVELOPMENT | 21 | 194 | 2.453e-08 | 4.717e-07 |
243 | CARDIAC CHAMBER DEVELOPMENT | 18 | 144 | 2.652e-08 | 5.079e-07 |
244 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 38 | 552 | 2.811e-08 | 5.36e-07 |
245 | STEM CELL PROLIFERATION | 12 | 60 | 2.866e-08 | 5.442e-07 |
246 | REGULATION OF NEURON DEATH | 24 | 252 | 3.052e-08 | 5.772e-07 |
247 | REGULATION OF ADHERENS JUNCTION ORGANIZATION | 11 | 50 | 3.811e-08 | 7.18e-07 |
248 | SKELETAL SYSTEM MORPHOGENESIS | 21 | 201 | 4.564e-08 | 8.562e-07 |
249 | RESPONSE TO WOUNDING | 38 | 563 | 4.716e-08 | 8.813e-07 |
250 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 15 | 103 | 4.918e-08 | 9.153e-07 |
251 | REGULATION OF MAP KINASE ACTIVITY | 27 | 319 | 5.058e-08 | 9.376e-07 |
252 | RESPONSE TO ALCOHOL | 29 | 362 | 5.377e-08 | 9.928e-07 |
253 | RESPONSE TO HORMONE | 51 | 893 | 5.553e-08 | 1.021e-06 |
254 | REGULATION OF PROTEIN BINDING | 19 | 168 | 5.632e-08 | 1.028e-06 |
255 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 15 | 104 | 5.615e-08 | 1.028e-06 |
256 | REGULATION OF CELL MATRIX ADHESION | 14 | 90 | 5.865e-08 | 1.066e-06 |
257 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 7 | 16 | 6.057e-08 | 1.097e-06 |
258 | PROTEIN LOCALIZATION | 83 | 1805 | 6.665e-08 | 1.202e-06 |
259 | DORSAL VENTRAL PATTERN FORMATION | 14 | 91 | 6.773e-08 | 1.217e-06 |
260 | NEGATIVE REGULATION OF LOCOMOTION | 24 | 263 | 6.9e-08 | 1.235e-06 |
261 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 16 | 121 | 7.104e-08 | 1.266e-06 |
262 | REGULATION OF INTRACELLULAR TRANSPORT | 40 | 621 | 7.326e-08 | 1.301e-06 |
263 | NEGATIVE REGULATION OF NEURON DEATH | 19 | 171 | 7.492e-08 | 1.325e-06 |
264 | AMEBOIDAL TYPE CELL MIGRATION | 18 | 154 | 7.578e-08 | 1.336e-06 |
265 | REGULATION OF SYNAPSE ASSEMBLY | 13 | 79 | 8.786e-08 | 1.543e-06 |
266 | REGULATION OF PROTEIN TARGETING | 26 | 307 | 8.854e-08 | 1.549e-06 |
267 | NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 10 | 43 | 9.075e-08 | 1.581e-06 |
268 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 18 | 156 | 9.25e-08 | 1.606e-06 |
269 | POSITIVE REGULATION OF TRANSPORT | 52 | 936 | 9.834e-08 | 1.701e-06 |
270 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 12 | 67 | 1.045e-07 | 1.802e-06 |
271 | COGNITION | 23 | 251 | 1.201e-07 | 2.062e-06 |
272 | MUSCLE ORGAN DEVELOPMENT | 24 | 277 | 1.824e-07 | 3.121e-06 |
273 | REGULATION OF APOPTOTIC SIGNALING PATHWAY | 28 | 363 | 2.006e-07 | 3.418e-06 |
274 | CARDIAC SEPTUM DEVELOPMENT | 13 | 85 | 2.141e-07 | 3.637e-06 |
275 | NEGATIVE REGULATION OF BINDING | 16 | 131 | 2.178e-07 | 3.684e-06 |
276 | NEPHRON DEVELOPMENT | 15 | 115 | 2.185e-07 | 3.684e-06 |
277 | REGULATION OF MEMBRANE POTENTIAL | 27 | 343 | 2.213e-07 | 3.717e-06 |
278 | MODULATION OF SYNAPTIC TRANSMISSION | 25 | 301 | 2.275e-07 | 3.807e-06 |
279 | AXIS ELONGATION | 8 | 27 | 2.344e-07 | 3.909e-06 |
280 | REGULATION OF EPITHELIAL CELL MIGRATION | 18 | 166 | 2.388e-07 | 3.969e-06 |
281 | NEGATIVE REGULATION OF TRANSPORT | 32 | 458 | 2.586e-07 | 4.283e-06 |
282 | SINGLE ORGANISM CELL ADHESION | 32 | 459 | 2.716e-07 | 4.481e-06 |
283 | MESODERM DEVELOPMENT | 15 | 118 | 3.076e-07 | 5.057e-06 |
284 | IMMUNE SYSTEM DEVELOPMENT | 37 | 582 | 3.174e-07 | 5.2e-06 |
285 | REGULATION OF STEM CELL PROLIFERATION | 13 | 88 | 3.247e-07 | 5.302e-06 |
286 | CELL DEATH | 53 | 1001 | 3.356e-07 | 5.46e-06 |
287 | CARDIAC SEPTUM MORPHOGENESIS | 10 | 49 | 3.394e-07 | 5.502e-06 |
288 | IN UTERO EMBRYONIC DEVELOPMENT | 25 | 311 | 4.212e-07 | 6.804e-06 |
289 | AXIS SPECIFICATION | 13 | 90 | 4.245e-07 | 6.834e-06 |
290 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 15 | 121 | 4.283e-07 | 6.872e-06 |
291 | STRIATED MUSCLE CELL DIFFERENTIATION | 18 | 173 | 4.44e-07 | 7.052e-06 |
292 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 35 | 541 | 4.436e-07 | 7.052e-06 |
293 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 35 | 541 | 4.436e-07 | 7.052e-06 |
294 | POSITIVE REGULATION OF JUN KINASE ACTIVITY | 11 | 63 | 4.667e-07 | 7.362e-06 |
295 | SKIN DEVELOPMENT | 20 | 211 | 4.668e-07 | 7.362e-06 |
296 | REGULATION OF FAT CELL DIFFERENTIATION | 14 | 106 | 4.736e-07 | 7.445e-06 |
297 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 21 | 232 | 5.209e-07 | 8.161e-06 |
298 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 28 | 381 | 5.364e-07 | 8.375e-06 |
299 | SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 7 | 21 | 5.514e-07 | 8.581e-06 |
300 | REGULATION OF VASCULATURE DEVELOPMENT | 21 | 233 | 5.593e-07 | 8.674e-06 |
301 | RENAL TUBULE DEVELOPMENT | 12 | 78 | 5.88e-07 | 9.09e-06 |
302 | EAR DEVELOPMENT | 19 | 195 | 5.916e-07 | 9.115e-06 |
303 | MUSCLE TISSUE DEVELOPMENT | 23 | 275 | 6.132e-07 | 9.417e-06 |
304 | NEPHRON EPITHELIUM DEVELOPMENT | 13 | 93 | 6.256e-07 | 9.575e-06 |
305 | RESPONSE TO NITROGEN COMPOUND | 47 | 859 | 6.504e-07 | 9.922e-06 |
306 | NEGATIVE REGULATION OF GROWTH | 21 | 236 | 6.903e-07 | 1.05e-05 |
307 | RESPONSE TO INORGANIC SUBSTANCE | 32 | 479 | 6.964e-07 | 1.055e-05 |
308 | FORMATION OF PRIMARY GERM LAYER | 14 | 110 | 7.503e-07 | 1.134e-05 |
309 | RESPONSE TO EXTERNAL STIMULUS | 80 | 1821 | 7.723e-07 | 1.163e-05 |
310 | POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 7 | 22 | 7.912e-07 | 1.176e-05 |
311 | SOMATIC STEM CELL DIVISION | 7 | 22 | 7.912e-07 | 1.176e-05 |
312 | POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY | 7 | 22 | 7.912e-07 | 1.176e-05 |
313 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 23 | 279 | 7.892e-07 | 1.176e-05 |
314 | NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 16 | 144 | 8e-07 | 1.186e-05 |
315 | POSITIVE REGULATION OF BINDING | 15 | 127 | 8.052e-07 | 1.189e-05 |
316 | IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 25 | 323 | 8.502e-07 | 1.252e-05 |
317 | METANEPHROS DEVELOPMENT | 12 | 81 | 8.938e-07 | 1.308e-05 |
318 | MUSCLE CELL DEVELOPMENT | 15 | 128 | 8.912e-07 | 1.308e-05 |
319 | LEUKOCYTE ACTIVATION | 29 | 414 | 9.003e-07 | 1.313e-05 |
320 | CARDIOCYTE DIFFERENTIATION | 13 | 96 | 9.078e-07 | 1.32e-05 |
321 | CELL CELL ADHESION | 37 | 608 | 9.132e-07 | 1.324e-05 |
322 | KIDNEY MORPHOGENESIS | 12 | 82 | 1.023e-06 | 1.479e-05 |
323 | BETA CATENIN TCF COMPLEX ASSEMBLY | 9 | 43 | 1.055e-06 | 1.519e-05 |
324 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 37 | 616 | 1.246e-06 | 1.789e-05 |
325 | EMBRYONIC AXIS SPECIFICATION | 8 | 33 | 1.282e-06 | 1.83e-05 |
326 | POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 8 | 33 | 1.282e-06 | 1.83e-05 |
327 | CELLULAR RESPONSE TO ALCOHOL | 14 | 115 | 1.295e-06 | 1.843e-05 |
328 | REGULATION OF ION TRANSPORT | 36 | 592 | 1.308e-06 | 1.856e-05 |
329 | NEGATIVE REGULATION OF PHOSPHORYLATION | 29 | 422 | 1.325e-06 | 1.874e-05 |
330 | REGULATION OF AXONOGENESIS | 17 | 168 | 1.368e-06 | 1.928e-05 |
331 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 15 | 133 | 1.458e-06 | 2.049e-05 |
332 | REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 10 | 57 | 1.487e-06 | 2.084e-05 |
333 | RESPONSE TO ABIOTIC STIMULUS | 52 | 1024 | 1.522e-06 | 2.126e-05 |
334 | RESPONSE TO STEROID HORMONE | 32 | 497 | 1.544e-06 | 2.151e-05 |
335 | NEGATIVE REGULATION OF CELL GROWTH | 17 | 170 | 1.613e-06 | 2.239e-05 |
336 | SKIN EPIDERMIS DEVELOPMENT | 11 | 71 | 1.617e-06 | 2.239e-05 |
337 | HEART VALVE DEVELOPMENT | 8 | 34 | 1.64e-06 | 2.251e-05 |
338 | REGULATION OF EXTENT OF CELL GROWTH | 13 | 101 | 1.636e-06 | 2.251e-05 |
339 | BRAIN MORPHOGENESIS | 8 | 34 | 1.64e-06 | 2.251e-05 |
340 | LEUKOCYTE DIFFERENTIATION | 23 | 292 | 1.731e-06 | 2.368e-05 |
341 | NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 15 | 135 | 1.763e-06 | 2.392e-05 |
342 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 15 | 135 | 1.763e-06 | 2.392e-05 |
343 | EMBRYONIC PATTERN SPECIFICATION | 10 | 58 | 1.757e-06 | 2.392e-05 |
344 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 13 | 102 | 1.832e-06 | 2.478e-05 |
345 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 18 | 191 | 1.895e-06 | 2.555e-05 |
346 | PEPTIDYL THREONINE MODIFICATION | 9 | 46 | 1.926e-06 | 2.582e-05 |
347 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 36 | 602 | 1.925e-06 | 2.582e-05 |
348 | EYE MORPHOGENESIS | 15 | 136 | 1.936e-06 | 2.589e-05 |
349 | CELLULAR RESPONSE TO HORMONE STIMULUS | 34 | 552 | 1.955e-06 | 2.606e-05 |
350 | POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 14 | 119 | 1.961e-06 | 2.608e-05 |
351 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 13 | 103 | 2.049e-06 | 2.709e-05 |
352 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 13 | 103 | 2.049e-06 | 2.709e-05 |
353 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 32 | 505 | 2.168e-06 | 2.858e-05 |
354 | NEGATIVE REGULATION OF CELL CYCLE | 29 | 433 | 2.214e-06 | 2.91e-05 |
355 | POSITIVE REGULATION OF PROTEIN IMPORT | 13 | 104 | 2.288e-06 | 2.999e-05 |
356 | CHONDROCYTE DIFFERENTIATION | 10 | 60 | 2.426e-06 | 3.17e-05 |
357 | SYSTEM PROCESS | 77 | 1785 | 2.565e-06 | 3.343e-05 |
358 | REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 14 | 122 | 2.647e-06 | 3.44e-05 |
359 | CALCIUM MEDIATED SIGNALING | 12 | 90 | 2.816e-06 | 3.638e-05 |
360 | REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 11 | 75 | 2.823e-06 | 3.638e-05 |
361 | MESONEPHROS DEVELOPMENT | 12 | 90 | 2.816e-06 | 3.638e-05 |
362 | MEMBRANE DEPOLARIZATION | 10 | 61 | 2.836e-06 | 3.644e-05 |
363 | CARDIAC VENTRICLE DEVELOPMENT | 13 | 106 | 2.843e-06 | 3.644e-05 |
364 | REGULATION OF MUSCLE HYPERTROPHY | 8 | 37 | 3.262e-06 | 4.169e-05 |
365 | SOMITOGENESIS | 10 | 62 | 3.306e-06 | 4.214e-05 |
366 | INNER EAR MORPHOGENESIS | 12 | 92 | 3.563e-06 | 4.53e-05 |
367 | REGULATION OF CATENIN IMPORT INTO NUCLEUS | 7 | 27 | 3.69e-06 | 4.654e-05 |
368 | REGULATION OF BMP SIGNALING PATHWAY | 11 | 77 | 3.679e-06 | 4.654e-05 |
369 | INOSITOL PHOSPHATE MEDIATED SIGNALING | 6 | 18 | 3.69e-06 | 4.654e-05 |
370 | REGULATION OF CARTILAGE DEVELOPMENT | 10 | 63 | 3.841e-06 | 4.818e-05 |
371 | REGULATION OF EPIDERMIS DEVELOPMENT | 10 | 63 | 3.841e-06 | 4.818e-05 |
372 | WOUND HEALING | 30 | 470 | 3.907e-06 | 4.887e-05 |
373 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 21 | 263 | 3.931e-06 | 4.904e-05 |
374 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 53 | 1087 | 3.956e-06 | 4.922e-05 |
375 | MESENCHYME MORPHOGENESIS | 8 | 38 | 4.04e-06 | 5.013e-05 |
376 | NEURON MIGRATION | 13 | 110 | 4.32e-06 | 5.346e-05 |
377 | ACTIN FILAMENT BASED PROCESS | 29 | 450 | 4.706e-06 | 5.793e-05 |
378 | SEX DIFFERENTIATION | 21 | 266 | 4.695e-06 | 5.793e-05 |
379 | NEGATIVE REGULATION OF PROTEIN BINDING | 11 | 79 | 4.754e-06 | 5.836e-05 |
380 | DOPAMINERGIC NEURON DIFFERENTIATION | 7 | 28 | 4.814e-06 | 5.894e-05 |
381 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 8 | 39 | 4.971e-06 | 6.055e-05 |
382 | NEGATIVE CHEMOTAXIS | 8 | 39 | 4.971e-06 | 6.055e-05 |
383 | FOREBRAIN DEVELOPMENT | 25 | 357 | 5.128e-06 | 6.224e-05 |
384 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 14 | 129 | 5.137e-06 | 6.224e-05 |
385 | REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 6 | 19 | 5.279e-06 | 6.373e-05 |
386 | EAR MORPHOGENESIS | 13 | 112 | 5.287e-06 | 6.373e-05 |
387 | REGULATION OF HORMONE LEVELS | 30 | 478 | 5.458e-06 | 6.563e-05 |
388 | POSITIVE REGULATION OF CELL GROWTH | 15 | 148 | 5.576e-06 | 6.687e-05 |
389 | LENS DEVELOPMENT IN CAMERA TYPE EYE | 10 | 66 | 5.925e-06 | 7.087e-05 |
390 | REGULATION OF FIBROBLAST PROLIFERATION | 11 | 81 | 6.093e-06 | 7.27e-05 |
391 | POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 19 | 228 | 6.11e-06 | 7.272e-05 |
392 | STEM CELL DIVISION | 7 | 29 | 6.207e-06 | 7.349e-05 |
393 | REGULATION OF HEART MORPHOGENESIS | 7 | 29 | 6.207e-06 | 7.349e-05 |
394 | RESPONSE TO CYTOKINE | 39 | 714 | 6.301e-06 | 7.441e-05 |
395 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 13 | 114 | 6.44e-06 | 7.586e-05 |
396 | POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 9 | 53 | 6.618e-06 | 7.776e-05 |
397 | CELLULAR RESPONSE TO DRUG | 10 | 67 | 6.808e-06 | 7.98e-05 |
398 | CARTILAGE MORPHOGENESIS | 5 | 12 | 7.016e-06 | 8.182e-05 |
399 | REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 5 | 12 | 7.016e-06 | 8.182e-05 |
400 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 17 | 190 | 7.339e-06 | 8.537e-05 |
401 | TONGUE DEVELOPMENT | 6 | 20 | 7.38e-06 | 8.542e-05 |
402 | POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 6 | 20 | 7.38e-06 | 8.542e-05 |
403 | LYMPHOCYTE ACTIVATION | 24 | 342 | 7.631e-06 | 8.811e-05 |
404 | HAIR CYCLE | 11 | 83 | 7.751e-06 | 8.883e-05 |
405 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 15 | 152 | 7.736e-06 | 8.883e-05 |
406 | MOLTING CYCLE | 11 | 83 | 7.751e-06 | 8.883e-05 |
407 | POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 7 | 30 | 7.92e-06 | 9.055e-05 |
408 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 15 | 153 | 8.381e-06 | 9.558e-05 |
409 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 12 | 100 | 8.588e-06 | 9.77e-05 |
410 | LEUKOCYTE CELL CELL ADHESION | 20 | 255 | 8.691e-06 | 9.863e-05 |
411 | NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 11 | 84 | 8.718e-06 | 9.87e-05 |
412 | EPITHELIAL CELL MORPHOGENESIS | 8 | 42 | 8.921e-06 | 0.0001005 |
413 | POSITIVE REGULATION OF AXONOGENESIS | 10 | 69 | 8.922e-06 | 0.0001005 |
414 | REGULATION OF KIDNEY DEVELOPMENT | 9 | 55 | 9.078e-06 | 0.000102 |
415 | CAMERA TYPE EYE MORPHOGENESIS | 12 | 101 | 9.526e-06 | 0.0001068 |
416 | GLAND DEVELOPMENT | 26 | 395 | 1.007e-05 | 0.0001127 |
417 | NEURAL PRECURSOR CELL PROLIFERATION | 10 | 70 | 1.018e-05 | 0.0001135 |
418 | REGULATION OF MUSCLE SYSTEM PROCESS | 17 | 195 | 1.036e-05 | 0.0001153 |
419 | BONE DEVELOPMENT | 15 | 156 | 1.061e-05 | 0.0001178 |
420 | DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 18 | 216 | 1.069e-05 | 0.0001184 |
421 | REGULATION OF CELL FATE SPECIFICATION | 5 | 13 | 1.116e-05 | 0.0001231 |
422 | GANGLION DEVELOPMENT | 5 | 13 | 1.116e-05 | 0.0001231 |
423 | EXTRACELLULAR STRUCTURE ORGANIZATION | 22 | 304 | 1.127e-05 | 0.0001239 |
424 | REGULATION OF DENDRITE DEVELOPMENT | 13 | 120 | 1.134e-05 | 0.0001244 |
425 | POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 21 | 282 | 1.154e-05 | 0.0001264 |
426 | ENDOCARDIAL CUSHION DEVELOPMENT | 7 | 32 | 1.253e-05 | 0.0001366 |
427 | PATTERNING OF BLOOD VESSELS | 7 | 32 | 1.253e-05 | 0.0001366 |
428 | REGULATION OF SYNAPTIC PLASTICITY | 14 | 140 | 1.33e-05 | 0.0001446 |
429 | POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT | 6 | 22 | 1.361e-05 | 0.0001476 |
430 | CEREBRAL CORTEX DEVELOPMENT | 12 | 105 | 1.423e-05 | 0.0001536 |
431 | ODONTOGENESIS | 12 | 105 | 1.423e-05 | 0.0001536 |
432 | SECOND MESSENGER MEDIATED SIGNALING | 15 | 160 | 1.44e-05 | 0.000155 |
433 | ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 14 | 141 | 1.443e-05 | 0.000155 |
434 | POSITIVE REGULATION OF PROTEIN BINDING | 10 | 73 | 1.489e-05 | 0.0001597 |
435 | RESPONSE TO METAL ION | 23 | 333 | 1.521e-05 | 0.0001627 |
436 | VASCULOGENESIS | 9 | 59 | 1.64e-05 | 0.000175 |
437 | REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 9 | 60 | 1.886e-05 | 0.0002009 |
438 | REGULATION OF MESENCHYMAL CELL PROLIFERATION | 7 | 34 | 1.917e-05 | 0.0002037 |
439 | OSTEOBLAST DIFFERENTIATION | 13 | 126 | 1.926e-05 | 0.0002041 |
440 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 9 | 61 | 2.164e-05 | 0.0002288 |
441 | EPITHELIAL CELL DEVELOPMENT | 16 | 186 | 2.216e-05 | 0.0002338 |
442 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 15 | 166 | 2.233e-05 | 0.000234 |
443 | REGULATION OF CELL DIVISION | 20 | 272 | 2.231e-05 | 0.000234 |
444 | TELENCEPHALON DEVELOPMENT | 18 | 228 | 2.225e-05 | 0.000234 |
445 | POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 6 | 24 | 2.351e-05 | 0.0002453 |
446 | RESPONSE TO STEROL | 6 | 24 | 2.351e-05 | 0.0002453 |
447 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 45 | 926 | 2.388e-05 | 0.000248 |
448 | OSSIFICATION | 19 | 251 | 2.386e-05 | 0.000248 |
449 | MESENCHYMAL TO EPITHELIAL TRANSITION | 5 | 15 | 2.497e-05 | 0.0002562 |
450 | PEPTIDYL SERINE MODIFICATION | 14 | 148 | 2.5e-05 | 0.0002562 |
451 | NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 5 | 15 | 2.497e-05 | 0.0002562 |
452 | REGULATION OF CATABOLIC PROCESS | 38 | 731 | 2.497e-05 | 0.0002562 |
453 | REGULATION OF SMOOTHENED SIGNALING PATHWAY | 9 | 62 | 2.475e-05 | 0.0002562 |
454 | CELLULAR RESPONSE TO STEROL | 5 | 15 | 2.497e-05 | 0.0002562 |
455 | LYMPHOCYTE DIFFERENTIATION | 17 | 209 | 2.556e-05 | 0.0002614 |
456 | POSITIVE REGULATION OF CYTOKINE PRODUCTION | 24 | 370 | 2.79e-05 | 0.0002847 |
457 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 11 | 95 | 2.853e-05 | 0.0002899 |
458 | HEAD MORPHOGENESIS | 7 | 36 | 2.847e-05 | 0.0002899 |
459 | POSITIVE REGULATION OF CATABOLIC PROCESS | 25 | 395 | 2.869e-05 | 0.0002909 |
460 | OVULATION CYCLE | 12 | 113 | 3.001e-05 | 0.0003036 |
461 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 6 | 25 | 3.027e-05 | 0.0003056 |
462 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 29 | 498 | 3.152e-05 | 0.0003175 |
463 | POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 15 | 171 | 3.166e-05 | 0.0003182 |
464 | REGULATION OF PHOSPHOLIPASE ACTIVITY | 9 | 64 | 3.213e-05 | 0.0003222 |
465 | CELLULAR MACROMOLECULE LOCALIZATION | 55 | 1234 | 3.353e-05 | 0.0003355 |
466 | REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 8 | 50 | 3.397e-05 | 0.0003377 |
467 | REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 8 | 50 | 3.397e-05 | 0.0003377 |
468 | RHO PROTEIN SIGNAL TRANSDUCTION | 8 | 50 | 3.397e-05 | 0.0003377 |
469 | SYNAPTIC SIGNALING | 26 | 424 | 3.413e-05 | 0.0003386 |
470 | MYOBLAST DIFFERENTIATION | 7 | 37 | 3.435e-05 | 0.0003401 |
471 | PARAXIAL MESODERM DEVELOPMENT | 5 | 16 | 3.557e-05 | 0.0003507 |
472 | CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 5 | 16 | 3.557e-05 | 0.0003507 |
473 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 12 | 115 | 3.578e-05 | 0.0003512 |
474 | RESPONSE TO CALCIUM ION | 12 | 115 | 3.578e-05 | 0.0003512 |
475 | POSITIVE REGULATION OF CELL ADHESION | 24 | 376 | 3.61e-05 | 0.0003537 |
476 | PALLIUM DEVELOPMENT | 14 | 153 | 3.624e-05 | 0.0003543 |
477 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 23 | 352 | 3.645e-05 | 0.0003556 |
478 | REGULATION OF MESONEPHROS DEVELOPMENT | 6 | 26 | 3.852e-05 | 0.0003749 |
479 | POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 8 | 51 | 3.941e-05 | 0.0003828 |
480 | COLLAGEN FIBRIL ORGANIZATION | 7 | 38 | 4.12e-05 | 0.0003985 |
481 | POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 7 | 38 | 4.12e-05 | 0.0003985 |
482 | MESODERM MORPHOGENESIS | 9 | 66 | 4.129e-05 | 0.0003986 |
483 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 17 | 218 | 4.369e-05 | 0.0004209 |
484 | CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 14 | 156 | 4.493e-05 | 0.0004319 |
485 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 12 | 118 | 4.622e-05 | 0.0004434 |
486 | REGULATION OF LIPASE ACTIVITY | 10 | 83 | 4.651e-05 | 0.0004453 |
487 | HINDBRAIN DEVELOPMENT | 13 | 137 | 4.684e-05 | 0.0004475 |
488 | CYTOSKELETON ORGANIZATION | 41 | 838 | 4.771e-05 | 0.0004544 |
489 | REGULATION OF IMMUNE SYSTEM PROCESS | 60 | 1403 | 4.776e-05 | 0.0004544 |
490 | POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 6 | 27 | 4.847e-05 | 0.0004602 |
491 | REGULATION OF CHROMATIN BINDING | 5 | 17 | 4.934e-05 | 0.0004667 |
492 | POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 5 | 17 | 4.934e-05 | 0.0004667 |
493 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 13 | 138 | 5.054e-05 | 0.000476 |
494 | PLACENTA DEVELOPMENT | 13 | 138 | 5.054e-05 | 0.000476 |
495 | POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 10 | 84 | 5.161e-05 | 0.0004852 |
496 | NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 8 | 53 | 5.247e-05 | 0.0004912 |
497 | MESONEPHRIC TUBULE MORPHOGENESIS | 8 | 53 | 5.247e-05 | 0.0004912 |
498 | POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 29 | 514 | 5.561e-05 | 0.0005196 |
499 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 26 | 437 | 5.65e-05 | 0.0005269 |
500 | CHEMICAL HOMEOSTASIS | 42 | 874 | 5.787e-05 | 0.0005385 |
501 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 13 | 140 | 5.871e-05 | 0.0005452 |
502 | VENTRICULAR SEPTUM MORPHOGENESIS | 6 | 28 | 6.037e-05 | 0.0005574 |
503 | NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 6 | 28 | 6.037e-05 | 0.0005574 |
504 | VENTRICULAR SEPTUM DEVELOPMENT | 8 | 54 | 6.025e-05 | 0.0005574 |
505 | REGULATION OF DNA METABOLIC PROCESS | 22 | 340 | 6.195e-05 | 0.0005708 |
506 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 12 | 122 | 6.419e-05 | 0.0005902 |
507 | RESPONSE TO KETONE | 15 | 182 | 6.508e-05 | 0.0005972 |
508 | REPRODUCTION | 56 | 1297 | 6.734e-05 | 0.0006168 |
509 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 31 | 573 | 6.776e-05 | 0.0006195 |
510 | FC EPSILON RECEPTOR SIGNALING PATHWAY | 13 | 142 | 6.8e-05 | 0.0006204 |
511 | POSITIVE REGULATION OF KIDNEY DEVELOPMENT | 7 | 41 | 6.873e-05 | 0.0006254 |
512 | CRANIAL SKELETAL SYSTEM DEVELOPMENT | 8 | 55 | 6.896e-05 | 0.0006254 |
513 | REGULATION OF MITOTIC CELL CYCLE | 27 | 468 | 6.885e-05 | 0.0006254 |
514 | MULTICELLULAR ORGANISMAL SIGNALING | 12 | 123 | 6.952e-05 | 0.0006281 |
515 | T CELL DIFFERENTIATION | 12 | 123 | 6.952e-05 | 0.0006281 |
516 | ESTABLISHMENT OF PROTEIN LOCALIZATION | 60 | 1423 | 7.112e-05 | 0.0006413 |
517 | EPIDERMIS MORPHOGENESIS | 6 | 29 | 7.45e-05 | 0.0006666 |
518 | CARDIAC MUSCLE CELL CONTRACTION | 6 | 29 | 7.45e-05 | 0.0006666 |
519 | CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING | 9 | 71 | 7.428e-05 | 0.0006666 |
520 | CELL FATE SPECIFICATION | 9 | 71 | 7.428e-05 | 0.0006666 |
521 | OVULATION CYCLE PROCESS | 10 | 88 | 7.71e-05 | 0.0006885 |
522 | POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 23 | 370 | 7.814e-05 | 0.0006965 |
523 | SMAD PROTEIN SIGNAL TRANSDUCTION | 8 | 56 | 7.869e-05 | 0.0006974 |
524 | REGULATION OF DENDRITIC SPINE DEVELOPMENT | 8 | 56 | 7.869e-05 | 0.0006974 |
525 | NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 19 | 274 | 7.846e-05 | 0.0006974 |
526 | FAT CELL DIFFERENTIATION | 11 | 106 | 7.913e-05 | 7e-04 |
527 | NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 7 | 42 | 8.069e-05 | 0.0007111 |
528 | AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 7 | 42 | 8.069e-05 | 0.0007111 |
529 | ENDOTHELIAL CELL DIFFERENTIATION | 9 | 72 | 8.301e-05 | 0.0007302 |
530 | EPITHELIAL CELL PROLIFERATION | 10 | 89 | 8.492e-05 | 0.0007441 |
531 | POST EMBRYONIC DEVELOPMENT | 10 | 89 | 8.492e-05 | 0.0007441 |
532 | MYOTUBE DIFFERENTIATION | 8 | 57 | 8.953e-05 | 0.000783 |
533 | NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 6 | 30 | 9.115e-05 | 0.0007957 |
534 | EMBRYONIC HEART TUBE DEVELOPMENT | 9 | 73 | 9.259e-05 | 0.0008053 |
535 | REGULATION OF ORGAN GROWTH | 9 | 73 | 9.259e-05 | 0.0008053 |
536 | ENDOTHELIUM DEVELOPMENT | 10 | 90 | 9.341e-05 | 0.0008109 |
537 | REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 7 | 43 | 9.43e-05 | 0.0008155 |
538 | MORPHOGENESIS OF AN EPITHELIAL SHEET | 7 | 43 | 9.43e-05 | 0.0008155 |
539 | NEGATIVE REGULATION OF ION TRANSPORT | 12 | 127 | 9.486e-05 | 0.0008189 |
540 | REGULATION OF PEPTIDE TRANSPORT | 18 | 256 | 0.0001009 | 0.0008691 |
541 | REGULATION OF DENDRITE MORPHOGENESIS | 9 | 74 | 0.0001031 | 0.0008849 |
542 | ACTIN MEDIATED CELL CONTRACTION | 9 | 74 | 0.0001031 | 0.0008849 |
543 | SECRETION | 31 | 588 | 0.0001084 | 0.0009291 |
544 | BODY MORPHOGENESIS | 7 | 44 | 0.0001097 | 0.0009384 |
545 | REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 6 | 31 | 0.0001106 | 0.0009444 |
546 | REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 16 | 213 | 0.0001131 | 0.0009639 |
547 | MUSCLE SYSTEM PROCESS | 19 | 282 | 0.0001146 | 0.0009752 |
548 | NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 5 | 20 | 0.0001161 | 0.0009839 |
549 | TRACHEA DEVELOPMENT | 5 | 20 | 0.0001161 | 0.0009839 |
550 | POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 4 | 11 | 0.0001169 | 0.0009888 |
551 | EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 10 | 93 | 0.0001233 | 0.001039 |
552 | REGULATION OF DNA BINDING | 10 | 93 | 0.0001233 | 0.001039 |
553 | POSITIVE REGULATION OF CELL CYCLE | 21 | 332 | 0.0001244 | 0.001047 |
554 | LUNG MORPHOGENESIS | 7 | 45 | 0.0001271 | 0.001068 |
555 | SECRETION BY CELL | 27 | 486 | 0.0001287 | 0.001079 |
556 | REGULATION OF CELL SIZE | 14 | 172 | 0.0001292 | 0.001081 |
557 | REGULATION OF HORMONE SECRETION | 18 | 262 | 0.0001351 | 0.001122 |
558 | ACTION POTENTIAL | 10 | 94 | 0.0001349 | 0.001122 |
559 | RESPONSE TO BMP | 10 | 94 | 0.0001349 | 0.001122 |
560 | CELLULAR RESPONSE TO BMP STIMULUS | 10 | 94 | 0.0001349 | 0.001122 |
561 | MAINTENANCE OF CELL NUMBER | 12 | 132 | 0.0001374 | 0.001139 |
562 | REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 9 | 77 | 0.0001407 | 0.001165 |
563 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 22 | 360 | 0.000142 | 0.001174 |
564 | POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 8 | 61 | 0.000146 | 0.001205 |
565 | EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 7 | 46 | 0.0001467 | 0.001208 |
566 | NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 10 | 95 | 0.0001474 | 0.001212 |
567 | HOMEOSTATIC PROCESS | 56 | 1337 | 0.0001495 | 0.001227 |
568 | REGULATION OF CELLULAR COMPONENT SIZE | 21 | 337 | 0.0001531 | 0.001254 |
569 | PROTEIN COMPLEX SUBUNIT ORGANIZATION | 62 | 1527 | 0.0001543 | 0.001262 |
570 | NEGATIVE REGULATION OF ANION TRANSPORT | 6 | 33 | 0.0001594 | 0.001301 |
571 | MYELOID LEUKOCYTE DIFFERENTIATION | 10 | 96 | 0.0001609 | 0.001311 |
572 | CARDIAC VENTRICLE MORPHOGENESIS | 8 | 62 | 0.000164 | 0.001329 |
573 | POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 8 | 62 | 0.000164 | 0.001329 |
574 | EMBRYONIC HEART TUBE MORPHOGENESIS | 8 | 62 | 0.000164 | 0.001329 |
575 | REGULATION OF MICROTUBULE BASED PROCESS | 17 | 243 | 0.0001658 | 0.001342 |
576 | POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 7 | 47 | 0.0001686 | 0.001362 |
577 | DENDRITE DEVELOPMENT | 9 | 79 | 0.0001717 | 0.001381 |
578 | CELLULAR RESPONSE TO CHOLESTEROL | 4 | 12 | 0.0001718 | 0.001381 |
579 | TRACHEA MORPHOGENESIS | 4 | 12 | 0.0001718 | 0.001381 |
580 | REGULATION OF HAIR CYCLE | 5 | 22 | 0.0001891 | 0.001514 |
581 | MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION | 5 | 22 | 0.0001891 | 0.001514 |
582 | NEURAL TUBE PATTERNING | 6 | 34 | 0.0001895 | 0.001515 |
583 | MEMORY | 10 | 98 | 0.000191 | 0.001519 |
584 | NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 10 | 98 | 0.000191 | 0.001519 |
585 | REGULATION OF PROTEIN CATABOLIC PROCESS | 23 | 393 | 0.0001905 | 0.001519 |
586 | POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 7 | 48 | 0.0001932 | 0.001534 |
587 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 26 | 472 | 0.0001953 | 0.001543 |
588 | SKELETAL MUSCLE ORGAN DEVELOPMENT | 12 | 137 | 0.0001953 | 0.001543 |
589 | CELLULAR RESPONSE TO RADIATION | 12 | 137 | 0.0001953 | 0.001543 |
590 | REGULATED EXOCYTOSIS | 16 | 224 | 0.0002021 | 0.001594 |
591 | REGULATION OF BLOOD CIRCULATION | 19 | 295 | 0.0002052 | 0.001615 |
592 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 10 | 99 | 0.0002077 | 0.00163 |
593 | REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 10 | 99 | 0.0002077 | 0.00163 |
594 | POSITIVE REGULATION OF SECRETION | 22 | 370 | 0.0002092 | 0.001639 |
595 | CELLULAR RESPONSE TO CALCIUM ION | 7 | 49 | 0.0002205 | 0.001724 |
596 | POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 10 | 100 | 0.0002257 | 0.001762 |
597 | REGULATION OF CELL CYCLE PROCESS | 29 | 558 | 0.0002286 | 0.001782 |
598 | NEGATIVE REGULATION OF AXONOGENESIS | 8 | 65 | 0.0002291 | 0.001783 |
599 | REGULATION OF SECRETION | 34 | 699 | 0.0002356 | 0.00183 |
600 | REGULATION OF OSTEOBLAST PROLIFERATION | 5 | 23 | 0.0002366 | 0.001835 |
601 | HEMATOPOIETIC STEM CELL PROLIFERATION | 4 | 13 | 0.0002432 | 0.001877 |
602 | REGULATION OF SKELETAL MUSCLE ADAPTATION | 4 | 13 | 0.0002432 | 0.001877 |
603 | REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 4 | 13 | 0.0002432 | 0.001877 |
604 | REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 10 | 101 | 0.0002449 | 0.001887 |
605 | PROTEOGLYCAN METABOLIC PROCESS | 9 | 83 | 0.0002507 | 0.001923 |
606 | FACE DEVELOPMENT | 7 | 50 | 0.0002509 | 0.001923 |
607 | ENDODERM FORMATION | 7 | 50 | 0.0002509 | 0.001923 |
608 | CELLULAR RESPONSE TO UV | 8 | 66 | 0.000255 | 0.001949 |
609 | POSITIVE REGULATION OF LIPASE ACTIVITY | 8 | 66 | 0.000255 | 0.001949 |
610 | NEUROLOGICAL SYSTEM PROCESS | 52 | 1242 | 0.0002626 | 0.001999 |
611 | POSITIVE REGULATION OF AXON EXTENSION | 6 | 36 | 0.0002629 | 0.001999 |
612 | REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 6 | 36 | 0.0002629 | 0.001999 |
613 | REGULATION OF CYTOKINE PRODUCTION | 29 | 563 | 0.0002651 | 0.002012 |
614 | EPIDERMIS DEVELOPMENT | 17 | 253 | 0.0002672 | 0.002025 |
615 | POSITIVE REGULATION OF DNA METABOLIC PROCESS | 14 | 185 | 0.0002766 | 0.002092 |
616 | NEURAL CREST CELL MIGRATION | 7 | 51 | 0.0002845 | 0.002149 |
617 | REGULATION OF CIRCADIAN RHYTHM | 10 | 103 | 0.0002875 | 0.002168 |
618 | RAS PROTEIN SIGNAL TRANSDUCTION | 12 | 143 | 0.0002911 | 0.002192 |
619 | REGULATION OF PEPTIDE SECRETION | 15 | 209 | 0.0003009 | 0.002262 |
620 | ORGAN GROWTH | 8 | 68 | 0.0003141 | 0.002353 |
621 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 8 | 68 | 0.0003141 | 0.002353 |
622 | POSITIVE REGULATION OF DNA REPLICATION | 9 | 86 | 0.0003281 | 0.002454 |
623 | POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 4 | 14 | 0.0003337 | 0.00248 |
624 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 38 | 829 | 0.0003336 | 0.00248 |
625 | POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 4 | 14 | 0.0003337 | 0.00248 |
626 | MIDGUT DEVELOPMENT | 4 | 14 | 0.0003337 | 0.00248 |
627 | POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 17 | 258 | 0.0003356 | 0.002491 |
628 | SYNAPSE ASSEMBLY | 8 | 69 | 0.0003475 | 0.002575 |
629 | EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 5 | 25 | 0.0003583 | 0.002638 |
630 | REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 25 | 0.0003583 | 0.002638 |
631 | POSITIVE REGULATION OF ORGAN GROWTH | 6 | 38 | 0.000357 | 0.002638 |
632 | POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 5 | 25 | 0.0003583 | 0.002638 |
633 | POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 7 | 53 | 0.0003627 | 0.002662 |
634 | MAMMARY GLAND EPITHELIUM DEVELOPMENT | 7 | 53 | 0.0003627 | 0.002662 |
635 | MUSCLE ORGAN MORPHOGENESIS | 8 | 70 | 0.0003838 | 0.002812 |
636 | REGULATION OF RESPONSE TO WOUNDING | 23 | 413 | 0.0003863 | 0.002826 |
637 | NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 22 | 387 | 0.000389 | 0.002842 |
638 | POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 9 | 88 | 0.0003899 | 0.002843 |
639 | MALE SEX DIFFERENTIATION | 12 | 148 | 0.000399 | 0.002905 |
640 | RESPONSE TO EXTRACELLULAR STIMULUS | 24 | 441 | 0.0004055 | 0.002948 |
641 | REGULATION OF PHOSPHOLIPASE C ACTIVITY | 6 | 39 | 0.0004129 | 0.002993 |
642 | COCHLEA DEVELOPMENT | 6 | 39 | 0.0004129 | 0.002993 |
643 | REGULATION OF PROTEIN SECRETION | 22 | 389 | 0.0004172 | 0.003019 |
644 | POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 17 | 263 | 0.0004187 | 0.003025 |
645 | NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 8 | 71 | 0.0004231 | 0.003043 |
646 | ENDODERM DEVELOPMENT | 8 | 71 | 0.0004231 | 0.003043 |
647 | CELL CYCLE PROCESS | 46 | 1081 | 0.0004229 | 0.003043 |
648 | REGULATION OF MACROPHAGE ACTIVATION | 5 | 26 | 0.0004344 | 0.00311 |
649 | NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 5 | 26 | 0.0004344 | 0.00311 |
650 | REGULATION OF CELL FATE COMMITMENT | 5 | 26 | 0.0004344 | 0.00311 |
651 | REGULATION OF HAIR FOLLICLE DEVELOPMENT | 4 | 15 | 0.000446 | 0.003178 |
652 | REGULATION OF MESODERM DEVELOPMENT | 4 | 15 | 0.000446 | 0.003178 |
653 | BLASTODERM SEGMENTATION | 4 | 15 | 0.000446 | 0.003178 |
654 | REGULATION OF REPRODUCTIVE PROCESS | 11 | 129 | 0.0004499 | 0.003201 |
655 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 7 | 55 | 0.0004571 | 0.003247 |
656 | IMMUNE SYSTEM PROCESS | 74 | 1984 | 0.0004593 | 0.003258 |
657 | RESPONSE TO ESTROGEN | 15 | 218 | 0.0004706 | 0.003333 |
658 | FORELIMB MORPHOGENESIS | 6 | 40 | 0.0004755 | 0.003363 |
659 | PROTEIN LOCALIZATION TO CELL PERIPHERY | 12 | 151 | 0.0004786 | 0.003379 |
660 | LEARNING | 11 | 131 | 0.0005128 | 0.00361 |
661 | RETINA DEVELOPMENT IN CAMERA TYPE EYE | 11 | 131 | 0.0005128 | 0.00361 |
662 | HIPPO SIGNALING | 5 | 27 | 0.0005221 | 0.003664 |
663 | EXCITATORY POSTSYNAPTIC POTENTIAL | 5 | 27 | 0.0005221 | 0.003664 |
664 | COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 10 | 111 | 0.0005248 | 0.003678 |
665 | NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 6 | 41 | 0.0005453 | 0.003809 |
666 | LUNG ALVEOLUS DEVELOPMENT | 6 | 41 | 0.0005453 | 0.003809 |
667 | NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 22 | 397 | 0.0005487 | 0.003827 |
668 | CELL CYCLE ARREST | 12 | 154 | 0.0005713 | 0.003979 |
669 | CELL CYCLE | 53 | 1316 | 0.0005747 | 0.003997 |
670 | POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 4 | 16 | 0.0005828 | 0.004047 |
671 | ACTIN FILAMENT BASED MOVEMENT | 9 | 93 | 0.0005872 | 0.004072 |
672 | REGULATION OF TRANSMEMBRANE TRANSPORT | 23 | 426 | 0.0005931 | 0.004107 |
673 | NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 14 | 200 | 0.0006073 | 0.004198 |
674 | GASTRULATION WITH MOUTH FORMING SECOND | 5 | 28 | 0.0006225 | 0.004285 |
675 | REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 5 | 28 | 0.0006225 | 0.004285 |
676 | REGULATION OF NEUROBLAST PROLIFERATION | 5 | 28 | 0.0006225 | 0.004285 |
677 | PROTEIN LOCALIZATION TO NUCLEUS | 12 | 156 | 0.000641 | 0.004406 |
678 | POSITIVE REGULATION OF ENDOCYTOSIS | 10 | 114 | 0.0006479 | 0.004447 |
679 | NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 11 | 135 | 0.0006609 | 0.004529 |
680 | REGULATION OF CELL ACTIVATION | 25 | 484 | 0.000664 | 0.004543 |
681 | REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 6 | 43 | 0.0007084 | 0.004826 |
682 | CELL FATE DETERMINATION | 6 | 43 | 0.0007084 | 0.004826 |
683 | CEREBRAL CORTEX CELL MIGRATION | 6 | 43 | 0.0007084 | 0.004826 |
684 | ACTOMYOSIN STRUCTURE ORGANIZATION | 8 | 77 | 0.0007332 | 0.004987 |
685 | NEUROBLAST PROLIFERATION | 5 | 29 | 0.0007367 | 0.005004 |
686 | REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 4 | 17 | 0.0007469 | 0.005032 |
687 | ESTABLISHMENT OF TISSUE POLARITY | 4 | 17 | 0.0007469 | 0.005032 |
688 | REGULATION OF PROTEIN KINASE A SIGNALING | 4 | 17 | 0.0007469 | 0.005032 |
689 | REGULATION OF CALCINEURIN NFAT SIGNALING CASCADE | 4 | 17 | 0.0007469 | 0.005032 |
690 | FEMALE SEX DIFFERENTIATION | 10 | 116 | 0.0007425 | 0.005032 |
691 | ACTIVATION OF MAPK ACTIVITY | 11 | 137 | 0.0007473 | 0.005032 |
692 | MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 7 | 60 | 0.0007803 | 0.005247 |
693 | REGULATION OF CHROMOSOME ORGANIZATION | 17 | 278 | 0.0007828 | 0.005256 |
694 | SINGLE ORGANISM CELLULAR LOCALIZATION | 39 | 898 | 0.0007908 | 0.005302 |
695 | NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT | 10 | 117 | 0.0007939 | 0.005315 |
696 | REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 8 | 78 | 0.0007992 | 0.005343 |
697 | LABYRINTHINE LAYER DEVELOPMENT | 6 | 44 | 0.0008029 | 0.005352 |
698 | BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 6 | 44 | 0.0008029 | 0.005352 |
699 | REGULATION OF LEUKOCYTE PROLIFERATION | 14 | 206 | 0.0008119 | 0.005397 |
700 | FC RECEPTOR SIGNALING PATHWAY | 14 | 206 | 0.0008119 | 0.005397 |
701 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 9 | 98 | 0.0008597 | 0.005706 |
702 | EMBRYONIC DIGIT MORPHOGENESIS | 7 | 61 | 0.0008626 | 0.005717 |
703 | MYOTUBE CELL DEVELOPMENT | 5 | 30 | 0.0008658 | 0.005722 |
704 | CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 5 | 30 | 0.0008658 | 0.005722 |
705 | BONE MORPHOGENESIS | 8 | 79 | 0.0008699 | 0.005741 |
706 | THYMOCYTE AGGREGATION | 6 | 45 | 0.0009069 | 0.005956 |
707 | CELL JUNCTION ORGANIZATION | 13 | 185 | 0.0009075 | 0.005956 |
708 | SPROUTING ANGIOGENESIS | 6 | 45 | 0.0009069 | 0.005956 |
709 | T CELL DIFFERENTIATION IN THYMUS | 6 | 45 | 0.0009069 | 0.005956 |
710 | POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 9 | 99 | 0.0009249 | 0.006061 |
711 | REGULATION OF COLLATERAL SPROUTING | 4 | 18 | 0.0009412 | 0.006108 |
712 | RETINAL GANGLION CELL AXON GUIDANCE | 4 | 18 | 0.0009412 | 0.006108 |
713 | MUSCLE CONTRACTION | 15 | 233 | 0.0009347 | 0.006108 |
714 | NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 14 | 209 | 0.0009343 | 0.006108 |
715 | PHARYNGEAL SYSTEM DEVELOPMENT | 4 | 18 | 0.0009412 | 0.006108 |
716 | POST ANAL TAIL MORPHOGENESIS | 4 | 18 | 0.0009412 | 0.006108 |
717 | UTERUS DEVELOPMENT | 4 | 18 | 0.0009412 | 0.006108 |
718 | FOREBRAIN CELL MIGRATION | 7 | 62 | 0.0009515 | 0.006166 |
719 | RESPONSE TO MECHANICAL STIMULUS | 14 | 210 | 0.0009785 | 0.006332 |
720 | METENCEPHALON DEVELOPMENT | 9 | 100 | 0.000994 | 0.006424 |
721 | EXOCYTOSIS | 18 | 310 | 0.001009 | 0.00651 |
722 | MATERNAL PLACENTA DEVELOPMENT | 5 | 31 | 0.001011 | 0.006516 |
723 | REGULATION OF CHONDROCYTE DIFFERENTIATION | 6 | 46 | 0.001021 | 0.00657 |
724 | RESPONSE TO OXYGEN LEVELS | 18 | 311 | 0.001046 | 0.006722 |
725 | NEUROEPITHELIAL CELL DIFFERENTIATION | 7 | 63 | 0.001047 | 0.006722 |
726 | NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 11 | 143 | 0.001065 | 0.006824 |
727 | REGULATION OF HOMEOSTATIC PROCESS | 23 | 447 | 0.001132 | 0.007244 |
728 | POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 6 | 47 | 0.001146 | 0.007322 |
729 | POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 7 | 64 | 0.001151 | 0.007345 |
730 | PROTEIN DEPHOSPHORYLATION | 13 | 190 | 0.001159 | 0.007387 |
731 | REGULATION OF ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 4 | 19 | 0.001168 | 0.007419 |
732 | REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 4 | 19 | 0.001168 | 0.007419 |
733 | REGULATION OF ORGAN FORMATION | 5 | 32 | 0.001174 | 0.007419 |
734 | EMBRYONIC FORELIMB MORPHOGENESIS | 5 | 32 | 0.001174 | 0.007419 |
735 | POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 5 | 32 | 0.001174 | 0.007419 |
736 | BLOOD VESSEL REMODELING | 5 | 32 | 0.001174 | 0.007419 |
737 | REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS | 11 | 145 | 0.001192 | 0.007529 |
738 | EMBRYONIC PLACENTA DEVELOPMENT | 8 | 83 | 0.001204 | 0.007594 |
739 | CELL PROJECTION ASSEMBLY | 16 | 264 | 0.001213 | 0.007639 |
740 | REGULATION OF IMMUNE RESPONSE | 37 | 858 | 0.001215 | 0.00764 |
741 | STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 9 | 103 | 0.001227 | 0.007705 |
742 | REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 6 | 48 | 0.001282 | 0.007983 |
743 | REGULATION OF MYOBLAST DIFFERENTIATION | 6 | 48 | 0.001282 | 0.007983 |
744 | MYOFIBRIL ASSEMBLY | 6 | 48 | 0.001282 | 0.007983 |
745 | ANTERIOR POSTERIOR AXIS SPECIFICATION | 6 | 48 | 0.001282 | 0.007983 |
746 | POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 6 | 48 | 0.001282 | 0.007983 |
747 | PROTEIN AUTOPHOSPHORYLATION | 13 | 192 | 0.001275 | 0.007983 |
748 | TISSUE MIGRATION | 8 | 84 | 0.001302 | 0.008102 |
749 | REGULATION OF PROTEOLYSIS | 32 | 711 | 0.001307 | 0.008117 |
750 | EMBRYONIC EYE MORPHOGENESIS | 5 | 33 | 0.001355 | 0.008405 |
751 | SOMATIC STEM CELL POPULATION MAINTENANCE | 7 | 66 | 0.001382 | 0.00856 |
752 | RESPONSE TO UV | 10 | 126 | 0.001402 | 0.008664 |
753 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 10 | 126 | 0.001402 | 0.008664 |
754 | EPHRIN RECEPTOR SIGNALING PATHWAY | 8 | 85 | 0.001406 | 0.008679 |
755 | REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 6 | 49 | 0.00143 | 0.008811 |
756 | RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 18 | 321 | 0.001491 | 0.009179 |
757 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 17 | 296 | 0.001549 | 0.009521 |
758 | PROTEIN DESTABILIZATION | 5 | 34 | 0.001556 | 0.009549 |
759 | REGULATION OF HEART CONTRACTION | 14 | 221 | 0.001591 | 0.00974 |
760 | NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 14 | 221 | 0.001591 | 0.00974 |
761 | PEPTIDYL AMINO ACID MODIFICATION | 36 | 841 | 0.001599 | 0.009779 |
762 | CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 15 | 246 | 0.001606 | 0.009807 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | WNT PROTEIN BINDING | 16 | 31 | 4.874e-18 | 4.528e-15 |
2 | WNT ACTIVATED RECEPTOR ACTIVITY | 14 | 22 | 1.007e-17 | 4.677e-15 |
3 | FRIZZLED BINDING | 16 | 36 | 1.054e-16 | 3.265e-14 |
4 | BETA CATENIN BINDING | 19 | 84 | 2.441e-13 | 5.67e-11 |
5 | RECEPTOR BINDING | 84 | 1476 | 1.699e-12 | 3.157e-10 |
6 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 33 | 328 | 1.756e-11 | 2.331e-09 |
7 | ENZYME BINDING | 91 | 1737 | 1.702e-11 | 2.331e-09 |
8 | SIGNAL TRANSDUCER ACTIVITY | 88 | 1731 | 1.864e-10 | 2.165e-08 |
9 | REGULATORY REGION NUCLEIC ACID BINDING | 53 | 818 | 3.923e-10 | 4.049e-08 |
10 | PROTEIN KINASE ACTIVITY | 45 | 640 | 7.174e-10 | 6.664e-08 |
11 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 44 | 629 | 1.313e-09 | 1.109e-07 |
12 | MOLECULAR FUNCTION REGULATOR | 72 | 1353 | 1.621e-09 | 1.255e-07 |
13 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 24 | 226 | 3.599e-09 | 2.572e-07 |
14 | TRANSCRIPTION FACTOR BINDING | 38 | 524 | 6.985e-09 | 4.635e-07 |
15 | CYTOKINE BINDING | 15 | 92 | 1.019e-08 | 5.917e-07 |
16 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 28 | 315 | 9.88e-09 | 5.917e-07 |
17 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 30 | 371 | 2.561e-08 | 1.4e-06 |
18 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 63 | 1199 | 3.093e-08 | 1.597e-06 |
19 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 33 | 445 | 4.15e-08 | 2.029e-06 |
20 | KINASE ACTIVITY | 49 | 842 | 5.802e-08 | 2.695e-06 |
21 | PROTEIN DOMAIN SPECIFIC BINDING | 40 | 624 | 8.332e-08 | 3.686e-06 |
22 | SMAD BINDING | 12 | 72 | 2.387e-07 | 1.008e-05 |
23 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 14 | 104 | 3.731e-07 | 1.507e-05 |
24 | SEQUENCE SPECIFIC DNA BINDING | 54 | 1037 | 4.345e-07 | 1.682e-05 |
25 | GROWTH FACTOR BINDING | 15 | 123 | 5.309e-07 | 1.973e-05 |
26 | MACROMOLECULAR COMPLEX BINDING | 66 | 1399 | 7.407e-07 | 2.647e-05 |
27 | KINASE BINDING | 37 | 606 | 8.441e-07 | 2.904e-05 |
28 | DOUBLE STRANDED DNA BINDING | 43 | 764 | 9.553e-07 | 3.169e-05 |
29 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 51 | 992 | 1.352e-06 | 4.332e-05 |
30 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 17 | 172 | 1.897e-06 | 5.873e-05 |
31 | CALMODULIN BINDING | 17 | 179 | 3.282e-06 | 9.834e-05 |
32 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 11 | 81 | 6.093e-06 | 0.0001769 |
33 | G PROTEIN COUPLED RECEPTOR BINDING | 20 | 259 | 1.094e-05 | 0.000305 |
34 | ARMADILLO REPEAT DOMAIN BINDING | 5 | 13 | 1.116e-05 | 0.000305 |
35 | GROWTH FACTOR ACTIVITY | 15 | 160 | 1.44e-05 | 0.0003822 |
36 | PDZ DOMAIN BINDING | 11 | 90 | 1.703e-05 | 0.0004396 |
37 | CELL ADHESION MOLECULE BINDING | 16 | 186 | 2.216e-05 | 0.0005563 |
38 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 15 | 168 | 2.572e-05 | 0.0006288 |
39 | TRANSFORMING GROWTH FACTOR BETA BINDING | 5 | 16 | 3.557e-05 | 0.0008261 |
40 | RECEPTOR AGONIST ACTIVITY | 5 | 16 | 3.557e-05 | 0.0008261 |
41 | HEPARIN BINDING | 14 | 157 | 4.821e-05 | 0.001092 |
42 | CHROMATIN BINDING | 26 | 435 | 5.237e-05 | 0.001158 |
43 | ENZYME REGULATOR ACTIVITY | 45 | 959 | 5.518e-05 | 0.001192 |
44 | PHOSPHORIC ESTER HYDROLASE ACTIVITY | 23 | 368 | 7.2e-05 | 0.001498 |
45 | INTEGRIN BINDING | 11 | 105 | 7.255e-05 | 0.001498 |
46 | PROTEIN KINASE A BINDING | 7 | 42 | 8.069e-05 | 0.00163 |
47 | ACTIVATING TRANSCRIPTION FACTOR BINDING | 8 | 57 | 8.953e-05 | 0.00177 |
48 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 31 | 588 | 0.0001084 | 0.002099 |
49 | I SMAD BINDING | 4 | 11 | 0.0001169 | 0.002172 |
50 | VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 5 | 20 | 0.0001161 | 0.002172 |
51 | CYTOSKELETAL PROTEIN BINDING | 39 | 819 | 0.0001289 | 0.002259 |
52 | PROTEIN COMPLEX BINDING | 43 | 935 | 0.0001267 | 0.002259 |
53 | RECEPTOR REGULATOR ACTIVITY | 7 | 45 | 0.0001271 | 0.002259 |
54 | RECEPTOR ACTIVATOR ACTIVITY | 6 | 32 | 0.0001333 | 0.002292 |
55 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 12 | 133 | 0.0001476 | 0.002493 |
56 | RHO GTPASE BINDING | 9 | 78 | 0.0001555 | 0.00258 |
57 | GAMMA CATENIN BINDING | 4 | 12 | 0.0001718 | 0.0028 |
58 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 8 | 64 | 0.0002054 | 0.00329 |
59 | CAMP BINDING | 5 | 23 | 0.0002366 | 0.003669 |
60 | GLYCOSAMINOGLYCAN BINDING | 15 | 205 | 0.0002444 | 0.003669 |
61 | SIGNALING RECEPTOR ACTIVITY | 57 | 1393 | 0.0002376 | 0.003669 |
62 | CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 10 | 101 | 0.0002449 | 0.003669 |
63 | CYCLIC NUCLEOTIDE BINDING | 6 | 36 | 0.0002629 | 0.003876 |
64 | MITOGEN ACTIVATED PROTEIN KINASE BINDING | 5 | 24 | 0.0002927 | 0.004249 |
65 | SODIUM CHANNEL ACTIVITY | 6 | 37 | 0.0003071 | 0.004389 |
66 | SULFUR COMPOUND BINDING | 16 | 234 | 0.0003306 | 0.004592 |
67 | MAP KINASE ACTIVITY | 4 | 14 | 0.0003337 | 0.004592 |
68 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 10 | 105 | 0.0003361 | 0.004592 |
69 | PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 4 | 15 | 0.000446 | 0.005919 |
70 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 4 | 15 | 0.000446 | 0.005919 |
71 | DRUG BINDING | 10 | 109 | 0.000454 | 0.005941 |
72 | PROTEIN DIMERIZATION ACTIVITY | 48 | 1149 | 0.0004775 | 0.006161 |
73 | RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY | 9 | 92 | 0.0005423 | 0.006902 |
74 | TRANSCRIPTION COACTIVATOR ACTIVITY | 18 | 296 | 0.0005923 | 0.007436 |
75 | ADENYL NUCLEOTIDE BINDING | 59 | 1514 | 0.000636 | 0.007877 |
76 | EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 8 | 76 | 0.0006716 | 0.008209 |
77 | RECEPTOR ACTIVITY | 63 | 1649 | 0.0006893 | 0.008316 |
78 | STEROID HORMONE RECEPTOR ACTIVITY | 7 | 59 | 0.0007044 | 0.00839 |
79 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 15 | 228 | 0.0007494 | 0.008812 |
80 | RIBONUCLEOTIDE BINDING | 69 | 1860 | 0.0008407 | 0.009763 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | SYNAPSE | 57 | 754 | 1.63e-13 | 3.746e-11 |
2 | NEURON PROJECTION | 65 | 942 | 1.924e-13 | 3.746e-11 |
3 | CELL PROJECTION | 98 | 1786 | 1.46e-13 | 3.746e-11 |
4 | NEURON PART | 77 | 1265 | 6.026e-13 | 8.798e-11 |
5 | BETA CATENIN DESTRUCTION COMPLEX | 9 | 14 | 7.208e-12 | 8.419e-10 |
6 | WNT SIGNALOSOME | 8 | 11 | 2.492e-11 | 2.426e-09 |
7 | SYNAPSE PART | 46 | 610 | 4.566e-11 | 3.809e-09 |
8 | SOMATODENDRITIC COMPARTMENT | 47 | 650 | 1.154e-10 | 8.426e-09 |
9 | POSTSYNAPSE | 34 | 378 | 1.828e-10 | 1.186e-08 |
10 | EXTRACELLULAR MATRIX | 36 | 426 | 2.995e-10 | 1.749e-08 |
11 | PROTEINACEOUS EXTRACELLULAR MATRIX | 32 | 356 | 6.463e-10 | 3.431e-08 |
12 | EXCITATORY SYNAPSE | 23 | 197 | 1.206e-09 | 5.871e-08 |
13 | CELL PROJECTION PART | 56 | 946 | 3.311e-09 | 1.487e-07 |
14 | INTRACELLULAR VESICLE | 67 | 1259 | 6.457e-09 | 2.693e-07 |
15 | CYTOPLASMIC VESICLE PART | 41 | 601 | 1.008e-08 | 3.925e-07 |
16 | PHOSPHATASE COMPLEX | 10 | 48 | 2.763e-07 | 1.009e-05 |
17 | CELL SURFACE | 44 | 757 | 2.957e-07 | 1.016e-05 |
18 | ENDOCYTIC VESICLE MEMBRANE | 17 | 152 | 3.305e-07 | 1.072e-05 |
19 | EXTRACELLULAR SPACE | 66 | 1376 | 4.125e-07 | 1.268e-05 |
20 | CELL JUNCTION | 58 | 1151 | 4.633e-07 | 1.353e-05 |
21 | VESICLE MEMBRANE | 33 | 512 | 1.034e-06 | 2.876e-05 |
22 | CELL BODY | 32 | 494 | 1.357e-06 | 3.601e-05 |
23 | DENDRITE | 30 | 451 | 1.7e-06 | 4.317e-05 |
24 | TRANSCRIPTION FACTOR COMPLEX | 23 | 298 | 2.445e-06 | 5.949e-05 |
25 | ENDOCYTIC VESICLE | 21 | 256 | 2.568e-06 | 5.999e-05 |
26 | MEMBRANE REGION | 55 | 1134 | 3.004e-06 | 6.748e-05 |
27 | AXON | 28 | 418 | 3.302e-06 | 7.143e-05 |
28 | CYTOSKELETON | 82 | 1967 | 4.329e-06 | 9.03e-05 |
29 | SITE OF POLARIZED GROWTH | 15 | 149 | 6.058e-06 | 0.000122 |
30 | PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 6 | 20 | 7.38e-06 | 0.0001437 |
31 | VOLTAGE GATED SODIUM CHANNEL COMPLEX | 5 | 14 | 1.7e-05 | 0.0003128 |
32 | CELL CELL JUNCTION | 25 | 383 | 1.715e-05 | 0.0003128 |
33 | SARCOLEMMA | 13 | 125 | 1.767e-05 | 0.0003128 |
34 | APICAL JUNCTION COMPLEX | 13 | 128 | 2.281e-05 | 0.0003918 |
35 | PLASMA MEMBRANE REGION | 45 | 929 | 2.583e-05 | 0.000431 |
36 | PRESYNAPSE | 20 | 283 | 3.925e-05 | 0.0006367 |
37 | SODIUM CHANNEL COMPLEX | 5 | 17 | 4.934e-05 | 0.0007516 |
38 | MEMBRANE MICRODOMAIN | 20 | 288 | 5.019e-05 | 0.0007516 |
39 | PLASMA MEMBRANE PROTEIN COMPLEX | 29 | 510 | 4.839e-05 | 0.0007516 |
40 | NEURONAL POSTSYNAPTIC DENSITY | 8 | 53 | 5.247e-05 | 0.0007661 |
41 | ACTIN BASED CELL PROJECTION | 15 | 181 | 6.111e-05 | 0.0008704 |
42 | PLASMA MEMBRANE RAFT | 10 | 86 | 6.327e-05 | 0.0008798 |
43 | MICROTUBULE CYTOSKELETON | 48 | 1068 | 8.907e-05 | 0.00121 |
44 | RECEPTOR COMPLEX | 21 | 327 | 0.0001006 | 0.001336 |
45 | LAMELLIPODIUM | 14 | 172 | 0.0001292 | 0.001641 |
46 | T TUBULE | 7 | 45 | 0.0001271 | 0.001641 |
47 | FILOPODIUM | 10 | 94 | 0.0001349 | 0.001676 |
48 | ENDOPLASMIC RETICULUM LUMEN | 15 | 201 | 0.0001973 | 0.0024 |
49 | EXTRACELLULAR MATRIX COMPONENT | 11 | 125 | 0.0003432 | 0.004091 |
50 | NEUROMUSCULAR JUNCTION | 7 | 54 | 0.0004077 | 0.004762 |
51 | NUCLEAR CHROMATIN | 18 | 291 | 0.0004849 | 0.005545 |
52 | AXON PART | 15 | 219 | 0.0004938 | 0.005545 |
53 | CYTOSKELETAL PART | 57 | 1436 | 0.0005065 | 0.005581 |
54 | MICROVILLUS | 8 | 75 | 0.0006143 | 0.006643 |
55 | MICROTUBULE ORGANIZING CENTER | 30 | 623 | 0.0006385 | 0.006779 |
56 | CHROMATIN | 23 | 441 | 0.0009463 | 0.009868 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Wnt_signaling_pathway_hsa04310 | 91 | 146 | 2.816e-109 | 1.464e-107 | |
2 | Hippo_signaling_pathway_hsa04390 | 44 | 154 | 5.333e-34 | 1.387e-32 | |
3 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 37 | 139 | 1.619e-27 | 2.807e-26 | |
4 | mTOR_signaling_pathway_hsa04150 | 28 | 151 | 1.271e-16 | 1.652e-15 | |
5 | Adherens_junction_hsa04520 | 18 | 72 | 1.621e-13 | 1.549e-12 | |
6 | MAPK_signaling_pathway_hsa04010 | 34 | 295 | 1.787e-13 | 1.549e-12 | |
7 | Focal_adhesion_hsa04510 | 26 | 199 | 7.683e-12 | 5.707e-11 | |
8 | TGF_beta_signaling_pathway_hsa04350 | 17 | 84 | 3.013e-11 | 1.959e-10 | |
9 | Sphingolipid_signaling_pathway_hsa04071 | 18 | 118 | 1.045e-09 | 5.453e-09 | |
10 | cGMP_PKG_signaling_pathway_hsa04022 | 21 | 163 | 1.049e-09 | 5.453e-09 | |
11 | cAMP_signaling_pathway_hsa04024 | 23 | 198 | 1.333e-09 | 6.302e-09 | |
12 | Hedgehog_signaling_pathway_hsa04340 | 11 | 47 | 1.903e-08 | 8.248e-08 | |
13 | Calcium_signaling_pathway_hsa04020 | 20 | 182 | 4.101e-08 | 1.641e-07 | |
14 | Oocyte_meiosis_hsa04114 | 16 | 124 | 1.006e-07 | 3.738e-07 | |
15 | ErbB_signaling_pathway_hsa04012 | 13 | 85 | 2.141e-07 | 7.424e-07 | |
16 | FoxO_signaling_pathway_hsa04068 | 16 | 132 | 2.421e-07 | 7.87e-07 | |
17 | Rap1_signaling_pathway_hsa04015 | 20 | 206 | 3.173e-07 | 9.706e-07 | |
18 | Ras_signaling_pathway_hsa04014 | 21 | 232 | 5.209e-07 | 1.505e-06 | |
19 | PI3K_Akt_signaling_pathway_hsa04151 | 26 | 352 | 1.243e-06 | 3.402e-06 | |
20 | Cellular_senescence_hsa04218 | 16 | 160 | 3.256e-06 | 8.465e-06 | |
21 | Tight_junction_hsa04530 | 16 | 170 | 7.138e-06 | 1.768e-05 | |
22 | VEGF_signaling_pathway_hsa04370 | 9 | 59 | 1.64e-05 | 3.876e-05 | |
23 | Apelin_signaling_pathway_hsa04371 | 13 | 137 | 4.684e-05 | 0.0001059 | |
24 | Cell_cycle_hsa04110 | 12 | 124 | 7.523e-05 | 0.000163 | |
25 | HIF_1_signaling_pathway_hsa04066 | 10 | 100 | 0.0002257 | 0.0004694 | |
26 | Regulation_of_actin_cytoskeleton_hsa04810 | 15 | 208 | 0.0002858 | 0.0005717 | |
27 | Gap_junction_hsa04540 | 9 | 88 | 0.0003899 | 0.0007509 | |
28 | Phosphatidylinositol_signaling_system_hsa04070 | 9 | 99 | 0.0009249 | 0.001718 | |
29 | Cell_adhesion_molecules_.CAMs._hsa04514 | 11 | 145 | 0.001192 | 0.002138 | |
30 | Mitophagy_animal_hsa04137 | 7 | 65 | 0.001262 | 0.00215 | |
31 | Notch_signaling_pathway_hsa04330 | 6 | 48 | 0.001282 | 0.00215 | |
32 | p53_signaling_pathway_hsa04115 | 7 | 68 | 0.001647 | 0.002676 | |
33 | TNF_signaling_pathway_hsa04668 | 9 | 108 | 0.001712 | 0.002697 | |
34 | AMPK_signaling_pathway_hsa04152 | 9 | 121 | 0.003709 | 0.005673 | |
35 | Cytokine_cytokine_receptor_interaction_hsa04060 | 15 | 270 | 0.0039 | 0.005794 | |
36 | Jak_STAT_signaling_pathway_hsa04630 | 10 | 162 | 0.008443 | 0.0122 | |
37 | Phospholipase_D_signaling_pathway_hsa04072 | 9 | 146 | 0.01224 | 0.01721 | |
38 | Autophagy_animal_hsa04140 | 8 | 128 | 0.01639 | 0.02242 | |
39 | ECM_receptor_interaction_hsa04512 | 6 | 82 | 0.01785 | 0.0238 | |
40 | Hippo_signaling_pathway_multiple_species_hsa04392 | 3 | 29 | 0.03633 | 0.04722 | |
41 | Endocytosis_hsa04144 | 11 | 244 | 0.04743 | 0.06015 | |
42 | Apoptosis_multiple_species_hsa04215 | 3 | 33 | 0.05039 | 0.06239 | |
43 | NF_kappa_B_signaling_pathway_hsa04064 | 5 | 95 | 0.09383 | 0.1135 | |
44 | ABC_transporters_hsa02010 | 3 | 45 | 0.1054 | 0.1246 | |
45 | Autophagy_other_hsa04136 | 2 | 32 | 0.1943 | 0.2245 | |
46 | Lysosome_hsa04142 | 5 | 123 | 0.2025 | 0.2289 | |
47 | Necroptosis_hsa04217 | 6 | 164 | 0.2376 | 0.2628 | |
48 | Apoptosis_hsa04210 | 5 | 138 | 0.2726 | 0.2954 | |
49 | Phagosome_hsa04145 | 5 | 152 | 0.342 | 0.3629 | |
50 | Neuroactive_ligand_receptor_interaction_hsa04080 | 8 | 278 | 0.4084 | 0.4248 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | EMX2OS |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7f-2-3p;hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-5p;hsa-miR-224-3p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-374a-3p;hsa-miR-421;hsa-miR-484;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-624-5p;hsa-miR-629-3p;hsa-miR-7-1-3p | 40 | PRICKLE2 | Sponge network | -1.057 | 0.31716 | -0.551 | 0.42536 | 0.586 |
2 | CECR7 |
hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-491-5p;hsa-miR-502-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-7-5p | 27 | PRKCB | Sponge network | -0.551 | 0.56177 | 0.289 | 0.6299 | 0.583 |
3 | EMX2OS |
hsa-miR-1275;hsa-miR-144-3p;hsa-miR-146a-5p;hsa-miR-16-1-3p;hsa-miR-182-5p;hsa-miR-192-3p;hsa-miR-19b-1-5p;hsa-miR-26b-3p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-30d-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-484;hsa-miR-576-5p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-940 | 18 | SFRP1 | Sponge network | -1.057 | 0.31716 | -0.459 | 0.49771 | 0.573 |
4 | CECR7 |
hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-192-5p;hsa-miR-215-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-361-5p;hsa-miR-532-5p;hsa-miR-582-5p | 10 | PRICKLE1 | Sponge network | -0.551 | 0.56177 | -0.398 | 0.44256 | 0.538 |
5 | CECR7 |
hsa-miR-141-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-1976;hsa-miR-19b-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-592 | 10 | DAAM2 | Sponge network | -0.551 | 0.56177 | -0.123 | 0.86624 | 0.52 |
6 | EMX2OS |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-185-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-30b-3p;hsa-miR-30d-3p;hsa-miR-362-3p;hsa-miR-505-5p;hsa-miR-590-3p;hsa-miR-93-5p | 17 | TCF7L1 | Sponge network | -1.057 | 0.31716 | -0.403 | 0.47966 | 0.509 |
7 | CECR7 |
hsa-miR-130b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-940 | 14 | MAPK10 | Sponge network | -0.551 | 0.56177 | -0.278 | 0.49976 | 0.504 |
8 | EMX2OS |
hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7f-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-375;hsa-miR-424-5p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-484;hsa-miR-505-5p;hsa-miR-548o-3p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-940 | 44 | FZD4 | Sponge network | -1.057 | 0.31716 | -0.088 | 0.9264 | 0.501 |
9 | CECR7 |
hsa-miR-1275;hsa-miR-16-1-3p;hsa-miR-182-5p;hsa-miR-192-3p;hsa-miR-19b-1-5p;hsa-miR-26b-3p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-940 | 14 | SFRP1 | Sponge network | -0.551 | 0.56177 | -0.459 | 0.49771 | 0.494 |
10 | CECR7 |
hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7f-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-375;hsa-miR-429;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-505-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-940 | 40 | FZD4 | Sponge network | -0.551 | 0.56177 | -0.088 | 0.9264 | 0.486 |
11 | EMX2OS |
hsa-miR-1275;hsa-miR-146a-5p;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-93-3p | 13 | FZD1 | Sponge network | -1.057 | 0.31716 | 0.051 | 0.95908 | 0.447 |
12 | EMX2OS |
hsa-miR-141-5p;hsa-miR-144-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-1976;hsa-miR-19b-3p;hsa-miR-335-5p;hsa-miR-339-5p;hsa-miR-421;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-592 | 13 | DAAM2 | Sponge network | -1.057 | 0.31716 | -0.123 | 0.86624 | 0.445 |
13 | CECR7 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-505-5p;hsa-miR-590-3p;hsa-miR-93-5p | 15 | TCF7L1 | Sponge network | -0.551 | 0.56177 | -0.403 | 0.47966 | 0.437 |
14 | CECR7 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7f-2-3p;hsa-miR-130b-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-5p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-320a;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-361-5p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p | 38 | PRICKLE2 | Sponge network | -0.551 | 0.56177 | -0.551 | 0.42536 | 0.432 |
15 | MEG3 |
hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-32-3p;hsa-miR-429;hsa-miR-505-5p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-98-5p | 25 | FZD4 | Sponge network | -0.433 | 0.33816 | -0.088 | 0.9264 | 0.417 |
16 | EMX2OS |
hsa-miR-130b-3p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-454-3p;hsa-miR-548o-3p;hsa-miR-590-3p;hsa-miR-940 | 15 | MAPK10 | Sponge network | -1.057 | 0.31716 | -0.278 | 0.49976 | 0.408 |
17 | EMX2OS |
hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-452-3p;hsa-miR-484;hsa-miR-502-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-7-5p | 22 | PRKCB | Sponge network | -1.057 | 0.31716 | 0.289 | 0.6299 | 0.407 |
18 | MEG3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-30b-3p;hsa-miR-30d-3p;hsa-miR-429;hsa-miR-505-5p;hsa-miR-93-5p | 15 | TCF7L1 | Sponge network | -0.433 | 0.33816 | -0.403 | 0.47966 | 0.398 |
19 | MIAT |
hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-192-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-301a-3p;hsa-miR-424-5p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-505-5p;hsa-miR-92a-3p;hsa-miR-98-5p | 18 | FZD4 | Sponge network | 0.118 | 0.86338 | -0.088 | 0.9264 | 0.397 |
20 | MEG3 |
hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-19b-3p;hsa-miR-221-5p;hsa-miR-26a-2-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-320c;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-491-3p;hsa-miR-576-5p;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-7-1-3p | 26 | PRICKLE2 | Sponge network | -0.433 | 0.33816 | -0.551 | 0.42536 | 0.389 |
21 | CECR7 |
hsa-miR-1275;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-590-3p | 10 | FZD1 | Sponge network | -0.551 | 0.56177 | 0.051 | 0.95908 | 0.388 |
22 | HCG11 |
hsa-let-7g-3p;hsa-miR-107;hsa-miR-128-3p;hsa-miR-15b-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-33a-3p;hsa-miR-378a-5p;hsa-miR-511-5p;hsa-miR-590-3p;hsa-miR-7-1-3p | 11 | VANGL2 | Sponge network | -0.419 | 0.63279 | -0.77 | 0.42866 | 0.385 |
23 | CECR7 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1226-3p;hsa-miR-1227-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-331-3p;hsa-miR-335-5p;hsa-miR-532-3p;hsa-miR-589-3p | 13 | WNT9A | Sponge network | -0.551 | 0.56177 | 0.153 | 0.81191 | 0.363 |
24 | EMX2OS |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1227-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-185-3p;hsa-miR-193a-3p;hsa-miR-32-5p;hsa-miR-331-3p;hsa-miR-335-5p;hsa-miR-424-5p;hsa-miR-532-3p;hsa-miR-589-3p | 16 | WNT9A | Sponge network | -1.057 | 0.31716 | 0.153 | 0.81191 | 0.357 |
25 | MEG3 |
hsa-miR-146a-5p;hsa-miR-16-1-3p;hsa-miR-182-5p;hsa-miR-192-3p;hsa-miR-19b-1-5p;hsa-miR-29a-5p;hsa-miR-30d-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-96-5p | 13 | SFRP1 | Sponge network | -0.433 | 0.33816 | -0.459 | 0.49771 | 0.357 |
26 | EMX2OS |
hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-335-5p;hsa-miR-34a-5p;hsa-miR-362-3p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-940 | 12 | CAMK2B | Sponge network | -1.057 | 0.31716 | -2.17 | 0.00982 | 0.338 |
27 | MEG3 |
hsa-miR-146a-5p;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-577;hsa-miR-93-3p | 11 | FZD1 | Sponge network | -0.433 | 0.33816 | 0.051 | 0.95908 | 0.335 |
28 | HCG11 |
hsa-let-7a-3p;hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-197-3p;hsa-miR-212-3p;hsa-miR-26a-1-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p | 16 | PRICKLE2 | Sponge network | -0.419 | 0.63279 | -0.551 | 0.42536 | 0.335 |
29 | ZNF883 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7f-2-3p;hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18b-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-320a;hsa-miR-320c;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-5p | 30 | PRICKLE2 | Sponge network | -0.913 | 0.16772 | -0.551 | 0.42536 | 0.315 |
30 | CECR7 |
hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-200b-5p;hsa-miR-222-3p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-30c-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-7-5p | 12 | NFATC2 | Sponge network | -0.551 | 0.56177 | -0.208 | 0.70733 | 0.302 |
31 | CECR7 |
hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-491-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-940 | 12 | CAMK2B | Sponge network | -0.551 | 0.56177 | -2.17 | 0.00982 | 0.298 |
32 | MEG3 |
hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-577;hsa-miR-7-1-3p | 13 | WNT5A | Sponge network | -0.433 | 0.33816 | -0.11 | 0.91453 | 0.296 |
33 | EMX2OS |
hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-20a-5p;hsa-miR-215-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-486-5p;hsa-miR-590-3p | 10 | FZD7 | Sponge network | -1.057 | 0.31716 | -0.142 | 0.88753 | 0.278 |
34 | EMX2OS |
hsa-miR-193a-3p;hsa-miR-221-3p;hsa-miR-27a-3p;hsa-miR-324-5p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-374b-5p;hsa-miR-486-5p;hsa-miR-576-5p;hsa-miR-590-3p | 10 | DKK2 | Sponge network | -1.057 | 0.31716 | -0.674 | 0.21846 | 0.268 |
35 | MEG3 |
hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-7-1-3p | 17 | PRKCB | Sponge network | -0.433 | 0.33816 | 0.289 | 0.6299 | 0.266 |
36 | ZNF883 |
hsa-miR-144-3p;hsa-miR-146a-5p;hsa-miR-182-5p;hsa-miR-19b-1-5p;hsa-miR-26b-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-29a-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-576-5p | 11 | SFRP1 | Sponge network | -0.913 | 0.16772 | -0.459 | 0.49771 | 0.265 |
37 | EMX2OS |
hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-200b-5p;hsa-miR-222-3p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-7-5p | 13 | NFATC2 | Sponge network | -1.057 | 0.31716 | -0.208 | 0.70733 | 0.257 |